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ABSTRACT 
Ethanol and ionizing radiation exposure are independently known to cause tissue 
damage through various mechanisms. Non-enzymatic and enzymatic metabolism of 
ethanol, the latter via the cytochrome P450 2E1-dependent pathway, produces free radicals 
which deplete cellular glutathione (GSH). Ionizing radiation exposure has been shown to 
induce lipid peroxidation, DNA damage, protein oxidation, and GSH depletion, as well. 
It was postulated that initial exposure to ethanol, followed by ionizing radiation, would 
result in heightened oxidative stress. The in vitro model used in this investigation was 
HepG2 cells (human hepatocellular liver carcinoma cell line), while the in vivo model 
was CD-1 mice. The antioxidant status of the models was evaluated by an array of 
techniques. Levels of reduced glutathione, oxidized glutathione (GSSG), cysteine (CYS), 
and malondialdehyde (MDA) were measured by the HPLC method. Activities of 
antioxidant enzymes, catalase, and glutathione reductase (GR) were determined 
enzymatically. Apoptosis was evaluated by the caspase 3 assay and fluorescence 
microscopy. Our data showed that, in both of the models, combined treatment resulted in 
the lowest levels of GSH, and the highest MDA and GSSG levels compared with the 
control and single agent exposure. The catalase activity was significantly lower in the 
combined exposure groups, when compared to the single agent exposure groups, and the 
glutathione reductase activity was highest in the combined exposure groups and lowest in 
the control. These findings suggest that a combination of ethanol and ionizing radiation 
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1. INTRODUCTION 
 Ethanol and ionizing radiation exposure are known to independently cause tissue 
damage through various mechanisms. Non-enzymatic and enzymatic metabolism of 
ethanol, the latter via the cytochrome P450 2E1-dependent pathway, produces free radicals 
which deplete cellular glutathione (GSH). Acetaldehyde, an ethanol metabolite, has been 
documented to form adducts with proteins, that can induce an immune response in the 
liver, resulting in liver diseases such as hepatitis and cirrhosis. The metabolism of ethanol 
by the enzymes alcohol dehydrogenase and acetaldehyde dehydrogenase produce NADH, 
increasing the NADH/NAD+ ratio. High NADH/NAD+ hinders the oxidation of fatty 
acids, leading to fat accumulation in the liver, resulting in fatty liver disease. Ionizing 
radiation exposure has been shown to induce lipid peroxidation, DNA damage, protein 
oxidation, and GSH depletion. The damaging effects of ionizing radiation are mainly due 
to secondary radicals formed from radiolysis of water molecules in the cells. In spite of 
the dangers posed by ethanol and ionizing radiation exposure, the number of people 
exposed to these agents has continued to be on the rise as a result of increased use of 
radiation therapy in cancer treatment. Unfortunately, the habit of chronic alcohol 
consumption normally precedes tumor diagnosis in many individuals, and since ethanol 
consumption can be addictive, breaking the habit becomes extremely difficult, even when 
the health risks involved are obvious. Combined exposure studies would generate data 
that can elucidate on the dangers associated with heavy ethanol consumption, and educate 
the public before the consequences of their actions become irreversible. 
 
 
    
 2
1.1. REVIEW OF LITERATUTE 
1.1.1 Ethanol Consumption and Metabolism. Consumption of alcoholic 
beverages, containing varying percentages of ethanol, is widespread in every human 
society across the globe. In almost every human culture, social events, such as 
celebrations (St Pat’s Day, Independence Day), anniversaries, and parties are always 
punctuated with servings of alcoholic beverages as a part of the menu. Consumption of 
ethanol is documented as early as 8000 B.C [1]. In industrialized countries, alcoholic 
beverages are a part of the daily meals, while in developing countries, alcohol drinking is 
more often for pleasure and relaxation. The ethanol content of different beers, distilled 
spirits and wines varies a great deal. Low to moderate drinking of alcohol has been 
reported to have some inherent advantages such as cardioprotection, especially against 
coronary heart disease and ischemia-reperfusion injury [2], and provision of calories [3]. 
However, alcohol drinking can lead to alcoholism; a condition characterized by craving 
for alcohol and continued drinking in spite of alcohol-related problems, preoccupation 
with drug alcohol, and distortion in thinking, especially denial. In this condition, the 
alcohol addicts chronically take large amounts of alcoholic drinks and this leads to a 
number of medical conditions that are discussed later in the text. 
            There are great economic losses in terms of health care, reduced or lost 
productivity, destruction of property through accidents, and an increased crime rate 
which can be directly attributed to alcohol drinking. Between the years of 1985 and 1990, 
the economic cost of alcohol-related problems rose by 40% to $98.6 billion [4]. It has 
been estimated that 100,000 people die annually in the United States from drinking and 
related causes, making it the third leading cause of preventable mortality in the United 
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States [5]. Enzymatic pathways of ethanol metabolism produce two byproducts, namely 
acetaldehyde and NADH, which have adverse effects on the liver [6]. High 
concentrations of NADH in the liver inhibit the oxidation of fatty acids leading to their 
accumulation in the liver tissues. This results in a condition known as “fatty liver”. 
Acetaldehyde is known to react with many functional groups in proteins, thus impairing 
their function and leading to tissue damage [7]. Free radicals are also produced during 
both enzymatic and non-enzymatic ethanol metabolism, causing oxidative stress [6].  
Ethanol is highly soluble in water due to the hydrogen bonds it forms with water 
molecules. When ethanol is consumed, it easily crosses the cell membrane, enters the 
circulatory system, and is transported to various tissues and organs of the body such as 
the liver, the kidney and the brain. Ethanol crosses the blood brain barrier causing lipid 
peroxidation in the brain tissues [8]. This is because the brain is rich in polyunsaturated 
fatty acid side chains and is low in antioxidants [9]. The enzymatic pathway of ethanol 
metabolism through cytochrome P 4502E1 generates acetaldehyde and acetate and, in the 
process oxidizes, NADPH to NADP+. Because this pathway uses oxygen, it generates 
free radicals which cause tissue damage in the liver, leading to alcoholic hepatitis and 
cirrhosis [10]. This pathway also consumes NADPH which is used to reduce GSSG to 
GSH. This leads to a drop in GSH level, resulting in oxidative stress [11]. Catalase and 
alcohol dehydrogenase pathways of ethanol metabolism produce acetaldehyde. 
Acetaldehyde reacts with the protein’s various functional groups impairing their 
functions. The primary targets include erythrocyte membrane proteins, hemoglobin, 
albumin, tubulin, lipoproteins, and collagens [12].  
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Accumulation of NADH from ethanol metabolism inhibits the oxidation of fatty 
acids leading to a condition known as fatty liver. The free radicals produced during 
ethanol metabolism include: hydroxyethyl radical, super oxide radical, peroxy radical, 
and a host of other radicals.  
Ethanol is metabolized through enzymatic and non-enzymatic free radical 
pathways. The enzyme alcohol dehydrogenase catalyzes the oxidation of ethanol to 
acetaldehyde. This reaction takes place in the cytoplasm of the liver cells in the presence 
of NAD+. NADH is produced in the process. Acetaldehyde defuses into the mitochondria 
where aldehyde dehydrogenase enzyme catalyzes its metabolism to ethanoic acid and 
more NADH is produced [13]. Accumulation of NADH in the liver has been proved to be 
responsible for the fatty liver disease. Other enzymes involved in ethanol metabolism 
include catalase and cytochrome P-4502E1. 
The first step of ethanol metabolism through enzymatic pathways involves 
oxidation of ethanol to acetaldehyde. 
Alcohol Dehydrogenase: 
  CH3CH2OH + NAD+       Alcoholdehydrogenase    CH3CHO + NADH + H+  
Aldehyde Dehydrogenase: 
CH3CHO + NAD+ +H2O  Aldehydedehydrogenase       CH3COO- + NADH + H+ 
Catalase: 
CH3CH2OH + H2O2          Catalase                        CH3CHO + 2H2O 
Cytochrome P-4502E1: 
CH3CH2OH + NADPH + H+ + O2   CYP2E1      CH3CHO + 2H2O + NADP+
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Non-enzymatic free radical pathway of ethanol metabolism takes place when a 
hydroxyl radical abstracts a hydrogen atom from ethanol producing α- hydroxyethyl 
radical as follows: 
CH3CH2OH + •OH                                         CH3C•HOH + H2O 
Hypervalent iron complexes may also catalyze this reaction without apparent 
involvement of hydroxyl radical [14, 15]. 
The hydroxyethyl radical produced reacts with oxygen to form a peroxy radical 
intermediate, which rearranges to release acetaldehyde and a super oxide radical as 
follows: 
CH3C•HOH +O2                                      CH3C (OO•) HOH  
CH3C (OO•) HOH                                   CH3CHO + O2• -   +  H+
1.1.2. The Mechanism of Ethanol-Induced Oxidative Stress. The mechanism 
by which ethanol induces oxidative stress has been the subject of investigation by many 
leading scientists. Several mechanisms have been suggested to play an important role in 
how ethanol induces oxidative stress. Some of the suggested mechanisms include: redox 
state change (decrease in the NAD+/NADH ratio) as a result of metabolism of ethanol by 
alcohol dehydrogenase and aldehyde dehydrogenase; acetaldehyde, mitochondrial 
damage leading to less ATP production; Kupffer cell activation by endotoxin; membrane 
effects; induction of CYP2E1 by ethanol; ethanol mobilization of iron resulting in 
enhanced levels of low molecular weight non-heme iron; effect on antioxidant enzymes 
(particularly cytosolic and mitochondrial glutathione levels); one-electron oxidation of 
ethanol to 1-hydroxyethyl radical; and conversion of xanthine dehydrogenase to the 
xanthine oxidase form. These pathways are interrelated and contribute to ethanol-induced 
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oxidative stress. The CYP2E1 pathway of ethanol- induced oxidative stress has the 
consensus of many investigators as the major pathway by which ethanol induces 
oxidative stress.  
At high concentrations of ethanol and chronic ethanol consumption, alcohol 
dehydrogenase alone is not sufficient to metabolize all the ethanol. Under these 
circumstances, CYP2E1 becomes involved in ethanol oxidation [16]. CYP2E1 is mainly 
present in the liver; however, small quantities are present in other tissues such as the 
brain, kidney, and gastro-intestinal tract [17]. It has the ability to oxidize ethanol to 
generate reactive oxidation products such as acetaldehyde and the 1-hydroxyethyl radical. 
Additionally, it can activate various agents such as carbon tetrachloride, acetaminophen, 
benzene, halothane, halogenated alkanes, and alcohol to reactive products and generate 
reactive oxygen species. Ethanol increases levels of CYP2E1 by a posttranscriptional 
mechanism that leads to its stabilization against degradation. The catalytic cycle of 
CYP2E1, a loosely coupled enzyme, generates reactive oxygen species such as super 
oxide radical and hydrogen peroxide. The iron level is normally increased after ethanol 
treatment and enhances the production of more powerful oxidants such as hydroxyl 
radical, ferryl species, and 1-hydroxyethyl radical. Toxicity of these reactive oxygen 
species is due to protein oxidation and enzyme inactivation and damage to the cell 
membrane through lipid peroxidation, and production of reactive lipid aldehydes such as 
malondialdehyde and 4-hydroxynonenal. Damage to mitochondrial membrane by the 
ROS leads to a decrease in the membrane potential and alters the membrane permeability. 
This causes apoptosis to occur due to the release of proapoptotic factors.  
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1.1.3. Evidence from Previous Research. There is strong evidence from research 
suggesting that ethanol induces developmental toxicity in organisms. Investigation 
conducted by Reimers et al. [18], using zebrafish exposed to ethanol and acetaldehyde 
established a number of developmental malfunctions such as pericardial edema, yolk sac 
edema, axial malformations,  delayed development and axial blistering. Reduced 
exposure to ethanol and acetaldehyde led to a proportional decrease in the effects. 
Studies conducted by Gohlke et al. [19] using rat models, investigated ethanol-
induced neocortical neuronal cell death during the synaptogenesis period. This study 
suggested that ethanol induces inhibition of proliferation during neurogenesis, and 
apoptosis. Sakuta et al. [20] have studied the relationship between heavy alcohol intake 
and homocysteine levels in type 2 diabetes. They found elevated levels of homocysteine 
in heavy alcohol drinking diabetic patients. Homocysteine is pro-oxidant [21], oxidizing 
low-density lipoproteins, thus enhancing the atherosclerosis process.  
Ethanol consumption has been implicated in deaths due to acute ethanol 
poisoning [22]. Jones et al. conducted a study in which they compared the blood-ethanol 
concentration in deaths attributed to acute alcohol poisoning and chronic alcoholism. 
Alcoholic ketoacidosis was suggested as a more probable cause of death since more death 
cases had very high concentrations of acetone in the blood. 
Research conducted by Agnieszka et al. [23] relates alcoholic liver cirrhosis and 
apoptosis of blood mononuclear cells. The result of their study showed that peripheral 
blood mononuclear cells (PBMCs), isolated from the blood of patients with alcoholic 
cirrhosis, showed accelerated spontaneous apoptosis after a 24-hr incubation period in in 
vitro compared to the PBMCs from the blood of healthy patient. 
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Besides the production of free radicals and the reactive oxygen species from 
ethanol metabolism, ethanol has been shown to increase the levels of bacterial protein 
called endotoxin in the blood and the liver [24]. The presence of endotoxin in the blood 
and the liver activates the immune cells called Kupffer cells in the liver to produce TNF-
α, which in turn, activate another type of cells (stellate cells) in the liver to produce 
transforming growth factor beta (TGF-β), and collagen, which promotes scar tissue 
formation (fibrosis). The release of other types of cytokines such as interleukin-8 (IL-8) 
is also induced by TNF-α. This leads to the attraction of the inflammatory cells from the 
blood stream to the liver, causing inflammation of the liver. The acetaldehyde produced 
during enzymatic metabolism of ethanol, forms adduct with proteins, lipids, and the DNA 
molecules. The presence of these adducts in the blood stream also lead to the activation 
of certain immune cells such as IL-1, IL-2 and TNF-α. The activation of these immune 
cells leads to the attraction of inflammatory cells to the liver, resulting in inflammation, 
fibrosis, and organ damage. A summary of all the pathways by which ethanol metabolism 
induces the production of reactive oxygen species, and activates the diverse pathways 
which lead to apoptosis and organ damage is illustrated in Figure 1.1. It is apparent that 
there are numerous pathways by which ethanol can cause tissue damage and the onset of 
disease. There seems to be endless pathological conditions that ethanol consumption can 
initiate. The on going research on ethanol and its effects on the biological systems has 
uncovered very essential mechanisms by which ethanol induces damage to tissues, and 






Figure 1.1. Pathways through which ethanol induces apoptosis and tissue damage [24]. 
 
 1.1.4. Ionizing Radiation. Ionizing radiation is high-energy radiation capable of 
producing ionization on the atoms of the molecules it comes into contact with. The atom 
Metabolism 
by CYP2E1


































becomes ionized when the radiation energy it absorbs is equal to or greater than the 
ionization energy of that atom, which results in an electron being ejected from the atom 
(illustrated in Figure 1.2). Alternatively, the energy absorbed may not be sufficient to 
eject an electron from an atom, resulting in excitation of an electron(s) (illustrated in 









 The radiations capable of producing such an effect on the atoms of the target 
molecules in the biological systems are called ionizing radiation. The particulate 
radiations (have high linear energy transfer) that travel short distances and release all of 
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their energies on their paths are the most ionizing. Alpha particles and neutrons are 








This type of effect is caused by low linear energy transfer radiations such as X-
rays and  γ-rays. The excited molecules produce secondary radicals, which in turn cause 
damage to the biological targets. 
1.1.5. Types of Ionizing Radiation. Ionizing radiation is classified as 
electromagnetic radiation, such as X-rays and γ-rays, and particulate radiations has forms 
such as α-particle and β-particles, neutrons and protons. X-rays are electromagnetic 
radiation of short wavelengths produced when high-speed electrons strike a solid target, 
while γ-rays are electromagnetic radiation produced by decomposition of unstable 
radionuclide. X-rays and γ-rays are low linear energy transfer radiation and produce most 
of their effects in the biological systems by indirect action, while particulate radiations 
(α-particles, neutrons, protons) are high linear energy transfer radiations and produce 
 
 12
their effects by direct action. Linear energy transfer (LET) is the number of ionizations 
which radiation causes per unit distance as it passes through the cells. The damaging 
effects of ionizing radiation are consequences of both direct and indirect actions. It has 
been estimated that 60%-70% of radiation-induced tissue damage is due to free radicals, 
particularly the hydroxyl radical (•OH) [26]. The DNA molecule is the most critical target 
of ionizing radiation, and suffers extensive oxidative damage by both direct and indirect 




Figure 1.4. A segment of the DNA molecule.  




The DNA suffers single and double strand breaks, and base modifications due to 
direct and indirect actions of radiation. Radiolysis of water produces •OH, which has been 
shown to produce the most damage to the DNA molecules [28]. 
1.1.6. Direct Action of Radiation. The direct action of radiation on biological 
systems is caused mostly by particulate radiation when the particles have sufficient 
kinetic energy to disrupt the atomic structure of the atoms of the absorbing molecule, 
resulting in chemical and biological changes. The alpha particles and neutrons are high 
LET radiations and produce their effects on biological systems by direct action.  
1.1.7. Indirect Action of Radiation. The indirect action of radiation is caused by 
electromagnetic radiations: X-rays and γ-rays, which do not produce biological changes 
themselves, but induce the production of free radicals, which mediate the radiation 
damage. When these radiations are absorbed by cells, the water in the cells becomes 
charged due to loss of the electron. 
H2O → H2O+ + e-  
The water molecule loses an electron as a result of the interaction with 
electromagnetic radiation to form a water radical cation, which is a strong acid. The water 
radical cation donates a proton to water, forming the hydronium ion and the hydroxyl 
radical. 
 H2O+ + H2O →H3O+ + •OH  
The hydroxyl radicals formed can react with biological targets such as DNA, 
proteins, lipids, and other molecules and structures in the cells, or recombine to form 
hydrogen peroxide 
 •OH + •OH → H2O2 
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The energy absorbed may, alternatively, cause radiolysis of water molecules to 
form the hydrogen and hydroxyl radicals. 
 H-O-H      
radiolysis
           •OH + H• 
The •OH radical formed by radiolysis of water molecules has been reported to 
damage 60%-70% of the DNA molecules. The interaction of free radicals with DNA 
bases and sugars produces the most significant damage to DNA, which includes: oxidized 
bases, DNA-DNA strand adducts, DNA single and double strand breaks, DNA-protein 
cross-links, and various forms of aberrations [29]. Guanine is the DNA base that is most 
susceptible to attack by free radical, forming 8-hydroxyguanine [30-31]. The attack on 
the sugar moieties leads to cleavage of the sugar-phosphate backbone of DNA resulting 
in strand breaks. The free radicals also attack proteins and lipids, resulting in protein 
oxidation and lipid peroxidation [32]. 
 
1.2. EFFECTS OF FREE RADICALS ON BIOLOGICAL SYSTEMS 
The free radicals produced by ethanol and ionizing radiation produce major 
biological changes, which can be classified as DNA damage, lipid peroxidation, and 
protein oxidation [33]. 
1.2.1. DNA Damage. The DNA molecule has many specific sites that are prone 
to attack (hot spots) by the ROS, as shown in Figure 1.5. The attacks can occur on the 
DNA bases or the sugar-phosphate backbone, resulting in DNA double and single strand 






Figure 1.5. Hot spots for free radical attack on the DNA molecule. 
(Freya Q. Schafer, PhD. Oxidative DNA damage. Sunrise Free Radical school, 1997) 
 
 
The attack on the DNA molecule by the •OH radical can fall in to three categories, 
namely, hydrogen abstraction, addition, and electron transfer [34]. These reactions have 
the potential of  causing damage to all of the four bases and the deoxyribose sugar.  
The •OH radical reacts with the bases in the DNA molecule by addition. In 
pyrimidines, such as thymine, the •OH radical adds to the C5-C6 double bond, forming 
base radicals, of which 5-hydroxy-6-yl radicals have reducing properties, while the 6-
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hydroxy-5-yl radicals are oxidizing [35]. The free radical can also abstract a hydrogen 
from the methyl group of thymine, resulting in radical formation. The reactions of the 












































Figure 1.6. Hydroxyl radical attack on thymine. 
(Adapted from: von Sontag C. (1987). The chemical basis of radiation biology, Taylo & 
Francis London, NY) 
 
 
The •OH radical  reacts with purines by adding to C4, C5, and C8 positions 
resulting in equal amounts of oxidizing and reducing adduct radicals [36]. The C4-OH 
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and C5-OH radicals dehydrate and are converted to oxidizing radicals [37]. These 
















































Figure 1.7. Hydroxyl radical attack on guanine (purine). 
(Adapted from: von Sontag C. (1987). The chemical basis of radiation biology, Taylo & 
Francis London, NY) 
 
 
A wide range of oxidized DNA base products are shown in Figure 1.8. These 
modifications have been suspected to be responsible for various types of mutations and 






Figure 1.8. Base products of oxidative damage to DNA [38]. 




Attack by the •OH radical on the deoxyribose sugar leads to an abstraction of 
hydrogen (possible in all the five carbons of the ribose sugar), and subsequent formation 
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of carbon-centered radicals. The carbon centered radicals can react with oxygen to form 
peroxyl radicals. Additionally, the radicals can react with each other forming non-radicals 
[39]. The C4’ –centered radical can undergo β cleavage under anaerobic conditions, 
resulting in DNA strand breakages and the release of an intact base and altered sugars 
[40]. The sugar lactone, and an intact base are formed when the C1’-centered radical is 






Figure 1.9. Attack of free radicals on the sugar phosphate backbone. 
(Adapted from: von Sontag C. (1987). The chemical basis of radiation biology, Taylo & 
Francis London, NY) 
 
 
These types of attacks result in single and double strand DNA breakages. The 
single strand breaks are normally easily repaired by the DNA repair enzymes. However, 
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the double strand breakages are very difficult to repair, and usually result in apoptosis, 
mutagenesis, and carcinogenesis [42]. 





Figure 1.10. Attack on the deoxyribose. 
(Adapted from: von Sontag C. (1987). The chemical basis of radiation biology, Taylo & 
Francis London, NY) 
 
 
The modified bases can react with proteins, forming DNA-protein cross-links, 
















































Figure 1.11. DNA-protein cross-link adducts. 
(Peak GJ, Peak MJ, et al., (1985). Photochem. Photobiol. 41. 295-302) 
 
 
1.2.2. Lipid Peroxidation. Lipid peroxidation is a biological free radical chain 
reaction that is responsible for the formation of a wide range of products, in including 
aldehydes, ketones, and cyclic peroxide radicals in the cells [44]. The mechanism of lipid 




























  Malondialdehyde 
Figure 1.12. Lipid peroxidation mechanism (polyunsaturated fatty acids). 
(Bucher JR, Tien M. et al., (1983). Biochem. Biophys. Res. Commun. 111: 777-784) 
 
 
The lipid peroxidation chain reaction is initiated by an abstraction of a hydrogen 
atom from a methylene carbon in a polyunsaturated fatty acid (such as arachidonic acid) 
by a hydroxyl radical, forming lipid radicals. The presence of many carbon-carbon 
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double bonds makes the abstraction of hydrogen easier. The carbon-centered lipid 
radicals formed rearrange and react with molecular oxygen in an aerobic environment to 
form peroxyl radicals. The peroxyl radicals formed abstract hydrogen from the side 
chains of neighboring polyunsaturated fatty acids (PUFA) and combine with the 
abstracted hydrogen to form hydroperoxides, and propagate the chain reaction; combine 
with each other, and attack membrane proteins [45]. The lipid hydroperoxides decompose 
in the presence of metals, such as iron or copper to form products, which include ethane 
and pentane gas, unsaturated aldehydes such as 4-hydroxy-2-nonenal (4-HNE), and 
malondialdehyde (MDA) [46-48]. Lipid peroxidation has been implicated in the 
pathological conditions associated with atherosclerosis, ischemic or traumatic brain 
damage [44].  
1.2.3. Protein Oxidation. Protein oxidation is the covalent modification of a 
protein induced either directly by reactive oxygen species or indirectly by reaction with 
secondary by-products of oxidative stress [49]. The damage caused on proteins due to 
oxidation can result in functional changes, which includes inhibition of enzymatic and 
binding activities; increased susceptibility to aggregation and proteolysis; decreased 
uptake by cells; altered immunogenisity; induction of apoptosis, and necrosis, altered 
gene regulation and expression, and modulation of cell signaling [50]. The oxidative 
changes can lead to backbone fragmentation, aliphatic-side chain oxidation, and aromatic 
side-chain oxidation. The ROS can abstract hydrogen from an α-carbon in an aliphatic 






















Figure 1.13. Sites of oxidant damage on proteins [51]. 




The abstraction of hydrogen at an alpha-carbon can result in backbone 
fragmentation. Side chain oxidation on aliphatic residue can occur at a tertiary carbon or 
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Figure 1.14. Side chain oxidation by radicals. 





Backbone fragmentation on a protein can occur when a hydrogen is abstracted 
from an alpha carbon, followed by addition of oxygen to form peroxyl radicals. The 
peroxyl radicals can undergo hydrolys, which results in fragmentation. Alternatively, the 
peroxyl radicals can abstract hydrogen from the neighboring molecules to form 
























































Figure 1.15. Backbone fragmentation induced by radicals [52]. 





The aromatic side chain oxidation occur by addition of hydroxyl radical on to the 
aromatic ring, leading to transformations from phenyalanine to ortho and meta-tyrosine 
product, and from tyrosine to 2,3-dihydroxyphenyalanine (DOPA) [53]. The 
transformations are shown in Figure 1.16. Protein oxidation products have been used as 































Figure 1.16. Specific aromatic side chain oxidation products [51]. 




1.3. THE ANTIOXIDANT DEFENSE SYSTEM 
Aerobic organisms have developed an elaborate system of antioxidant molecules 
and enzymes to counter the damaging effects of free radicals and reactive oxygen species 
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[54]. GSH is the most abundant antioxidant in the body, and is found in all mammalian 
cells. It is a tripeptide made of the amino acids: glutamate, cysteine, and glycine, as 
shown in Figure 1.17. The SH functional group in cysteine makes glutathione a potent 
antioxidant and the first line of defense against free radicals and xenobiotics. The 
antioxidant enzyme system is made of the enzymes: glutathione peroxidase, which 
decomposes organic and inorganic peroxides; glutathione reductase, which reduces 
oxidized glutathione to regenerate reduced glutathione; catalase, which decomposes 
hydrogen peroxide to water and oxygen; superoxide dismutase, which dismutates the 








Glutathione counters the oxidative stress by the following mechanisms: 
Free radical scavenging, 
GSH + OH•   → GS•   + H2O 
Hydrogen donation. 
R•  +  GSH → RH + GS•  
Restore oxidized DNA 
GSH + DNA•   →  DNA + GS•  
Regenerate other antioxidants 
Vit C•    + GSH → Vit C + GS•  
Reduce lipid peroxides  
2GSH + ROOH              
GPx               2H2O + ROH + GSSG 
 
1.4. SIGNIFICANCE OF COMBINED EXPOSURE STUDIES 
Studies have shown that, at high levels of exposure, chemical and physical agents 
may have additive/synergistic effects in the biological systems. Additionally, 
investigators have performed single agent exposure studies, while assuming that the agent 
under study would act independently of other preexisting conditions or agents [58]. 
Furthermore, the end points that have been measured by investigators in previous 
combined-exposure studies have been clinical outcomes, such as tumor induction, 
radiosensitization, or radioprotection, and not antioxidant status [59-61]. This 
investigation is the first complete combined-exposure investigation, using model in vitro 
and in vivo systems to determine the effects of a combination of ethanol and ionizing 
radiation on the antioxidant status of the systems. This study has the potential for 
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generating vital data that could be used to advise prospective radiation therapy patients. 
Additionally, this research offers a legitimate premise for advising the general public 
about the dangers of indulging in habits such as binge drinking and excessive use of 
alcohol. The on going research is bound to shed more light on effects of ethanol and 
radiation, and their interactions with biological systems. The onset of cancer generally 
occurs, in a majority of cases, from middle to old age, when habits such as cigarette 
smoking, alcoholism, and other habits are well established, and breaking such habits due 
to medical reasons always does not succeed. The data from this research can be used to 










2. EFFECTS OF COMBINED EXPOSURE TO ETHANOL AND IONIZING   
RADIATION ON THE ANTIOXIDANT STATUS OF AN  IN VITRO MODEL 
 
2.1. INTRODUCTION 
The combination of ionizing radiation and ethanol exposure can potentially be 
extremely toxic to tissues due to heightened oxidative stress. Ethanol and/or radiation 
exposure induce the production of reactive oxygen species (ROS) [62-66]. 
The enzymatic pathway of ethanol metabolism through cytochrome P4502E1 
(CYP 2E1) generates directly, besides acetaldehyde and acetate, ROS [67-68]. The latter 
can trigger protein oxidation, enzyme inactivation, DNA damage, damage to the cell 
membrane through lipid peroxidation, and production of reactive lipid aldehydes such as 
MDA and 4-hydroxynonenal (4HNE). This pathway also consumes NADPH, which is 
used to reduce GSSG to GSH, leading to a drop in the GSH levels of cells. Moreover, 
ROS are formed during the non-enzymatic oxidation of ethanol. Numerous studies have 
shown that ionizing radiation also generates ROS in biological systems, resulting in 
oxidative damage to macromolecules such as DNA, lipids and proteins [69-71].  
 Ionizing radiation can interact directly with critical targets in the cells, such as 
DNA by energy transfer, causing ionization of the atoms, and subsequent biological 
changes. Additionally, the radiation may also interact with water molecules to produce 
free radicals indirectly in a series of reactions: H2O → H2O+ + e-; H2O+ + H2O →H3O+ + 
•OH ;•OH + •OH→H2O2
These free radicals can then interact with macromolecules, such as DNA, to cause 
biological changes (indirect action). 
 
 31
 Chemotherapeutic and radiotherapeutic treatment modalities have relied on the 
oxidative damage by free radicals to eradicate tumors [72] and in the process, unintended 
damage to normal tissues often occurs. Since ethanol and ionizing radiation can both 
increase free radical levels significantly, the need to better understand the interplay of 
exposure to ethanol prior to ionizing radiation (XRT) becomes necessary. Assessment of 
risks in having some other agent or condition present prior to or coincident with radiation 
exposure, has usually relied on the implicit assumption that radiation would act 
independently of other pre-disposing conditions or substances already present in the 
system at the time of exposure. Recent studies of interactions, however, have shown that 
at high exposures, the action of one agent or condition can be influenced by simultaneous 
exposure to other agents or conditions [73]. There are numerous reports of investigations 
conducted to determine the effect of combined exposure of radiation with other physical 
and chemical agents, namely, tobacco, bleomycin, 5-fluorouracil, glutamine, N-acetyl 
cysteine, paraquat (superoxide generating agent), cyclophosphamide, and many others. 
The end points measured have been various including combined action against cancers, 
radiation protection of normal tissues, and tumor induction [74-75]. Other medical 
conditions, such as diabetes, hypertension, or collagen vascular diseases, may also affect 
the risks of complications attributed to XRT.  Therefore, in these sets of experiments, the 
effects of in vitro exposure of HepG2 cells to varying concentrations of ethanol for 24 h, 
followed by radiation, and then analysis 24 h later was investigated. In order to assess the 
antioxidant status, the parameters such as GSH, CYS, MDA, and activities of some 
antioxidant enzymes (catalase and glutathione reductase) were measured. Cell viability 
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was measured using the MTS assay and apoptosis by caspase-3 apoptotic assay and by 
fluorescence microscopy.  
 
2.2. EXPERIMENTAL DESIGN 
2.2.1. Ethanol Dose-Dependent Studies on HepG2 Cells. The ethanol dose 
dependent studies were conducted in order to determine the right concentration of ethanol 
to be used in the rest of the in vitro experiments. The cells were allowed a 24 h 
incubation period for attachment, followed by incubation with varying concentrations of 
ethanol (10-100 mM) for 48 h. At the end of the treatment period, the cells were collected 
by trypsinization, homogenized and derivatized, and levels of GSH determined. 
2.2.2. Radiation Dose-Dependent Studies on HepG2 Cells. These experiments 
were done in order to determine the right radiation dose to be used for the rest of the 
experiments. The cells were incubated for 24 h to allow attachment, followed by a change 
of media and further 24 h incubation, after which the cells were exposed to varying 
radiation doses (2-10 Gy). The cells were collected, homogenized, and derivatized to 
determine the GSH levels 24 h after irradiation. 
 2.2.3. Oxidative Stress Studies. The cellular levels of oxidative stress markers 
such as GSH, CYS, and MDA were measured after the cells had been exposed to ethanol, 
followed by ionizing radiation. The activities of some antioxidant enzymes (GR and 
CAT) were also measured. The objective of performing these experiments was to 
determine the antioxidant status of the cells, in order to assess the effects of ethanol and 
radiation on HepG2 cells. 
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2.2.4. Cell Viability Studies. The cell viability was determined by the MTS 
assay. The tetrazolium compound (MTS) was reduced to a formazan product by NADPH 
produced by the dehydrogenase enzyme in the living cells. The formazan product has an 
absorbance at 490 nm, which is directly proportional to the number of the living cells. 
The cells were exposed to ethanol followed by radiation, then the MTS reagent was 
added to the cell in a 96-well plate, and the absorbance was read after 2 h. The cell 
viabilities in the various groups were determined as the percentage of the untreated 
control. 
2.2.5. Apoptosis Studies. The caspase-3 assay and fluorescent microscopy 
procedures were used to determine the apoptotic process in the cells. The details of these 
procedures are given under the materials and methods section. 
 
 
2.3. MATERIALS AND METHODS 
2.3.1. Materials. HPLC-grade acetonitrile, glacial acetic acid, water, and 
phosphoric acid, used for the preparation of mobile phase, were purchased from Fisher 
Scientific (Fair Lawn, NJ USA). N-(1-pyrenyl)-maleimide (NPM), used as a derivatizing 
agent for measurement of CYS and GSH, 1,1,3,3-tetramethoxypropane, and ethanol were 
purchased from Aldrich (Milwaukee, WI USA). Protein concentration was evaluated with 
the Bradford reagent obtained from BioRad (Melville, NY USA). Dulbecco’s Modified 
Eagle Medium (DMEM), heat inactivated fetal bovine serum, L-glutaMax, penicillin 
and/streptomycin, sodium pyruvate, and non-essential amino acids were purchased from 
Invitrogen Corporation (Carlsbad, CA USA). Acridine orange (AO), ethidium bromide 
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(EB), and all other chemicals were purchased from Sigma (St. Louis, MO USA). 25 cm2 
culture flasks and 0.2-µm filters were purchased from Advantech MFS, Inc. (Dulin, CA 
USA). Human hepatocellular liver carcinoma (HepG2) cells were provided by Dr. Helen 
Anni from Thomas Jefferson University in Philadelphia, PA USA. Caspase-3 activity 
assay kit was purchased from R&D Systems, USA, while CAT and GR activity assay kits 
were purchased from OxisResearch ™. 
2.3.2. Culture of HepG2 Cells. HepG2 cells were grown in high glucose 
DMEM, supplemented with 1 % of L-glutaMax, penicillin and streptomycin, sodium 
pyruvate, non-essential amino acids, and 10 % heat inactivated fetal bovine serum (FBS). 
The cells were seeded at a density of 1.5 million cells per ml in T-25 culture flasks with 5 
ml of complete medium and cultured at 37 o C with 5 % carbon dioxide. 
2.3.3. Ethanol and Radiation Treatment. After 24 h, attached cells were treated 
with varying concentrations of ethanol (10-100 mM), for 24 h. Irradiation of the cells (8 
Gy) was performed with a 9 MeV beam generated by a Varian Linear accelerator, model 
21 EX (Varian Associates, Walnut Creek, CA, USA) using a 20 x 20 or 25 x 25 cm field 
at the Radiation Oncology Department of the Phelps County Regional Medical Center in 
Rolla, Missouri. The cells were further incubated for 24 h after radiation, and then 
trypsinized, homogenized, and immediately analyzed, or stored at -80 o C for later 
analysis of CYS, GSH, MDA, and antioxidant enzymatic activities. 
2.3.4. Thiols Determination. The derivatizing agent, N-(1-pyrenyl) maleimide, 
reacts with thiols (GSH, CYS, NAC, HCYS) to form a fluorescent adduct that can be 
quantified by the HPLC method, with fluorescent detection. This procedure was used to 
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determine the levels of glutathione and cysteine in HepG2 cells after homogenization and 
derivatization. 
2.3.5. Protein and Enzyme Activity Determination. A Hitachi U-2000 double 
beam UV-Vis spectrophotometer (Tokyo, Japan) was used to measure protein 
concentration using the Bradford assay [76] and antioxidant enzyme activities. A Fluostar 
OPTIMA microplate reader (BMG Labtechnologies. Inc, Durham, NC) was used for 
MTS and caspase-3 assays. 
2.3.6. Determination of GSH and CYS Levels. Cellular levels of GSH and CYS 
were determined by RP-HPLC, according to the method developed in our laboratory [77]. 
The HPLC system (Thermo Electron Corporation) consisted of a Finnigan Spectra 
System vacuum membrane degasser (model SCM1000), gradient pump (model P2000), 
autosampler (model AS3000), and fluorescence detector (model FL3000) with λex = 
330nm and λem = 376 nm. The HPLC column was a Reliasil ODS-1 C18 column (5 µm 
packing material) with 250 x 4.6 mm (Column Engineering, Ontario, CA, USA). The 
mobile phase was 70% acetonitrile and 30% water and was adjusted to a pH of 2 with 
acetic acid and o-phosphoric acid. The NPM derivatives of CYS and GSH were eluted 
from the column isocratically at a flow rate of 1mL/min. 
2.3.7. MDA Determination. The MDA determination was done by RP-HPLC 
method using λexc = 515 nm; the λem 550 nm [78]. Cell homogenate (350 μl) was mixed 
with butylated hydroxytoluene (100 μl of 500 ppm), and 10% trichloroacetic acid (550 
μl) and boiled for 30 min. After the solution was cooled on ice and centrifuged for 10 min 
at 1500 x g, the supernatant (500 μl) was mixed with thiobarbituric acid (TBA) (500 μl). 
The tubes were boiled again for 30 min, and then cooled on ice.  A solution (500 μl) was 
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added to n-butanol (1.0 ml), vortexed, and centrifuged for 5 min at 60 x g to facilitate a 
phase separation. The top layer was then filtered through 0.45 μm filters and injected 
onto a 5 μm C18 column (250 x 4.6 mm) on a RP- HPLC system. The mobile phase 
consisted of 69.4% 5mM sodium phosphate buffer pH = 7.0, 30% acetonitrile, and 0.6% 
tetrahydrofuran.  
2.3.8. Cell Viability Determination. This assay uses the novel tetrazolium 
compound, MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium), that is reduced by NADPH or NADH (produced by 
dehydrogenase enzyme in the living cells) into formazan, which is soluble in tissue 
culture medium. The Cell Titer 96® AQueous Cell Proliferation Assay (Promega 
Corporation, Madison, WI, USA) was used to determine of cell viability in the various 
groups. The absorbance of the formazan product was measured using 96-well microplates 
at 490 nm [79-80]. The production of formazan is proportional to the number of living 
cells; therefore, the intensity of the color produced is a good measure of cell viability. 
100 µL cell suspension of HepG2 cells (approximately 5 x 103 cells) were seeded into 
each well of the 96-well microplate and incubated for 24 h for the cells to attach. The old 
media was removed and fresh medium, with different concentrations of ethanol, was 
added to the ethanol groups. The control and XRT only groups received complete media 
without ethanol. The cells were incubated for an additional 24 h, then the XRT and 
ethanol and XRT groups were exposed to radiation, while the control group did not 
receive any radiation. The cells were returned to an incubator maintained at 37 o C, 95% 
air, and 5% CO2 for an additional 24 h after radiation. Then 20 µL of MTS tetrazolium 
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reagent were added to each well. The absorbance at 490 nm was read after 2 h incubation 
with the MTS reagent. 
2.3.9. Apoptosis Measurements. The caspase-3 apoptotic assay was performed 
using a colorimetric substrate, as per the manufacturer’s instructions (R&D Systems, Inc. 
MN). Briefly, 25µl of lysis buffer per 1x106 cells were added to each pellet that was 
collected after treatment. The cell suspension was incubated on ice for 10 min and then 
centrifuged at 10,000 x g for 3 min. 50 µl of the supernatant, along with 50 µl of the 2X 
reaction buffer containing 0.1 M dithiothreital (DTT) and 5 µl of the caspase-3 
colorimetric substrate (DEVD-pNA) were added to each well in a 96-well plate. The 
plate was then incubated for 2 h before the absorbance was read by a microplate reader at 
405 nm. 
Apoptosis was also evaluated by fluorescence microscopy. HepG2 cells (3.5 x 
106 cells/ml), were centrifuged at 150 x g for 5 min to pellet the cells, and then washed 
once with cold PBS (5 ml). The cells were resuspended in cold PBS (1 ml), and then 25 
µl of the cell suspension was mixed with 2 µl of EB/AO dye mix. Stained cells  (10 µl)  
were placed on a clean microscope slide and covered with a cover slip and viewed using 
an Olympus IX51 inverted microscope at  400X total magnification using a UPLFLN 
60X NA 1.25 objective. FITC (EX 482/35 506DM EM536/40) and TexasRed (EX 
562/40 593DM EM 692/40) filters were used (Brightline). Images were captured with a 
Hamamatsu ORCA285 CCD camera. Shutters, filters, and camera were controlled using 
SlideBook software (Intelligent Imaging Innovations, Denver, CO). 
2.3.10. Catalase Activity. The activity of catalase (CAT; EC 1.11.1.6) in the cell 
homogenates was measured spectrophotometrically at 240 nm following the exponential 
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disappearance of hydrogen peroxide (H2O2; 10 mM) according to the method described 
by Aebi [81]. The catalase activity is calculated from A60 = Ainitial e-kt where k, is the rate 
constant, Ainitial , is the initial absorbance, and A60 is the absorbance at 60 s. 
2.3.11. Glutathione Reductase Activity Assay. Glutathione reductase (GR; EC 
1.6.4.2) activity was measured spectro-photometrically at 340 nm following the decrease 
of NADPH using a commercial kit from OxisResearch™ (Portland, Oregon, U.S.A). This 
reaction maintains the normal levels of cellular glutathione, essential for keeping the 
levels of free radicals and organic peroxides down. 
2.3.12. Statistical Analysis. The data were analyzed with Student’s t test and one 
way ANOVA. Calibration curves were plotted and linear equations from the calibration 
standards were used to determine the parameters to be measured. All experiments were 
performed in triplicate, and the values reported are mean ± SD. 
 
 
2.4. IN VITRO RESULTS 
2.4.1. Ethanol Concentration Dependent Experiments. Figure 2.1 shows the 
results of increasing concentrations of ethanol (10 – 100 mM) on the levels of GSH in 
HepG2 cells The cells were exposed to different concentrations of ethanol for 48 h, and 
then GSH was measured. This experiment was performed to determine the optimal 
concentration of ethanol to be used in the combined exposure group. As can be seen from 
this figure, there is a nearly linear decrease in the level of GSH with an increasing 
concentration of ethanol. The GSH levels of the ethanol treated groups were significantly 













































Figure 2.1. Effects of ethanol (10 – 100 mM) on the levels of GSH in HepG2 cells. 
The cells were incubated with ethanol for 48 h, and then GSH levels were measured by 
the HPLC method after derivatization with NPM. The GSH levels decreased linearly with 
increases in ethanol concentration (pro: protein). 
 
 
2.4.2. Radiation Dose Dependent Experiments. Figure 2.2 shows how the levels 
of GSH in HepG2 cells vary when exposed to varying radiation doses (2 – 10 Gy). There 
is a nearly linear decrease in the levels of GSH that coincides with increases in radiation 
doses. The GSH levels in the radiation exposed groups are significantly lower than those 
of the control. This experiment was performed to determine the appropriate radiation 
















































Figure 2.2. Effects of radiation (2 – 10 Gy)  on the levels of GSH in HepG2 cells. 
Confluent cells were exposed to doses of radiation ranging from 2 to 10 Gy, and then 




2.4.3. GSH levels in Combined Exposure Experiments. Figure 2.3 shows the 
GSH levels in different treatment groups. Four groups, in triplicate, were designated as: 
(I) Control: no exposure to ethanol or radiation; (II) 50 mM ethanol, no radiation; (III) 
radiation (8 Gy), no ethanol; (IV) ethanol (50 mM) for 24 h, followed by radiation (8 
Gy). The GSH level in the control group  was significantly higher than those in the single 
agent and combined exposure groups. The GSH levels in the single agent (ethanol or 
radiation) exposure groups were significantly higher than those in the combined exposure 
group. The chromatograms in Figures 2.4 to 2.7 show changes in the areas under the 

































Figure 2.3. Combined effects of ethanol and radiation on the levels of GSH. 
 The levels of GSH were determined in groups designated as: control, ethanol only (50 
mM), radiation only (8 Gy), and ethanol (50 mM) + radiation (8Gy). The ethanol and 
radiation group was exposed to ethanol (50 mM) for 24 h, followed by radiation (8 Gy), 
then analysis 24 h later. * Significantly different compared to control (p < 0.05). ** 
Significantly different compared to combined exposure group (p < 0.05).  
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Figure 2.4. Chromatogram of control HepG2 cells.  
 
 42
The cells were incubated with a complete media only. Separation conditions: An ODS-1 
C18 Column (5 µm packing material) with 250 x 4.6 mm (i.d) was used for the separation. 
The NPM derivatives were measured by a fluorescence detector (λex = 330 nm and λem = 
376 nm). Flow rate was 1ml/min. The GSH peak at a retention time of 7.90 min was the 
highest, and the CYS peak was at retention time of 10.73 min. The hydrolysis peak (due 

























Figure 2.5. Chromatogram of HepG2 cells incubated with 50 mM ethanol. 




























Figure 2.6. Chromatogram of HepG2 cells exposed to radiation (8 Gy).  

























Figure 2.7. Chromatogram of HepG2 cells exposed to ethanol and radiation. 




2.4.4. Cysteine Levels. Figure 2.8 shows changes in the cysteine levels in the 
different treatment groups. The cysteine level in the control group  was higher than that in 
the ethanol (50 mM) only group, but significantly lower than the ethanol (50 mM) and 
radiation (8 Gy) groups. The control and radiation (8 Gy) only groups had almost the 


































Figure 2.8. Cysteine levels in the control and treatment groups. 50 mM ethanol decreased 
the level of cysteine significantly compared to control, while 8 Gy radiation had the same 
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level of cysteine as the control. The ethanol (50 mM) + radiation (8Gy) group had 




2.4.5. Catalase, Glutathione Reductase and Caspase-3 Results. Table 2.1 
displays the results of catalase, glutathione reductase, and caspase-3 activities as 
determined using enzyme assays. The catalase activity was significantly higher in the 
control as compared to the treatment groups. The single agent treatment groups had 
significantly higher catalase activity compared to that in the combined exposure groups. 
Glutathione reductase and caspase-3 activities were significantly higher in the combined 
exposure groups than those in both the single agent exposure groups and the control. 
 
 
Table 2.1. CAT, GR, and CAS-3 activities. 
 
Groups CAT (mU/mg pro) GR (U/mg pro CAS-3  
Control 2.47± 0.21 40.13 ± 2.44 0.262 ± 0.012 
EtOH  1.4 ± 0.12*/** 45.43 ± 2.59*/** 0.325 ± 0.037*/** 
XRT  1.65 ± 0.15*/** 47.4 ± 2.89*/** 0.366 ± 0.045*/** 
XRT + EtOH 1.16 ± 0.09* 51.15 ± 1.12* 0.661 ± 0.027* 
 
 
All the experiments were performed in triplicate, and the values reported are mean ± SD. 
* p < 0.05 compared to corresponding value of control group, ** p < 0.05 compared to 






2.4.6. MDA and MTS Results. Table 2.2 shows the results of ethanol and 
radiation exposure on MDA and MTS. The level of MDA, a marker of lipid peroxidation, 
was measured by using the HPLC method. The combined exposure groups had 
significantly higher MDA levels than both the single agent exposure and the control 
groups. Treating HepG2 cells with ethanol, and then exposing them to radiation, elevated 
MDA levels far beyond the levels obtained in the control, ethanol only, or radiation only 
groups. Metabolically active cells bioreduce the MTS to a colored formazan product in 
the culture media. The number of viable cell is determined by measuring the absorbance 
at 490 nm. A decrease in absorbance indicates less viability. The number of viable cells, 
as determined by the MTS assay was significantly higher in the control than in both the 
single agent exposure and the combined exposure groups. The single agent exposure 
groups had significantly higher cell viability than the combined exposure groups. The 
free radicals produced by irradiation attack on polyunsaturated fatty acids (PUFA) leads 
to the formation of MDA, along with other products. Ethanol increases the levels of 
CYP2E1 by a post-transcriptional mechanism, leading to the formation of stable adducts. 
During its catalytic cycle, CYP2E1, which has high NADPH oxidase activity [96], 
generates ROS and hydrogen peroxide, and in the presence of iron, Fenton reaction takes 
place, producing more harmful free radicals such as hydroxyl radicals, ferryl species, and 
1-hydroxyethyl radicals. These ROS damage the cell membranes through lipid 
peroxidation and the production of lipid aldehydes such as MDA and 4-hydroxynonenal. 
Increased levels of MDA is an indicator  of  elevated toxicity.  
2.4.7. Detection of Apoptosis in HepG2 Cells. Figure 2.9 (panels A through D) 
shows the images of HepG2 cells that were treated with 50 mM ethanol, 8 Gy radiation, 
50 mM ethanol and 8 Gy radiation for induction of apoptosis, and blank control. 
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Table 2.2.  MTS and MDA results. 
 
Groups MTS (% untreated control) MDA (nmol/100 mg pro) 
Control 100 ± 9.8 22.8± 1.83 
EtOH  84.5 ± 6.39*/** 27.9 ± 1.55*/** 
XRT  72.8 ± 9.46*/** 24.7 ± 2.06*/** 
XRT + EtOH 60.4 ± 4.8* 29.5 ± 2.23* 
 
 
The experiments were performed in triplicate, and values presented as mean ± SD.  * p < 
0.05 compared to corresponding value of control group, ** p < 0.05 compared to 




The cells were observed using a fluorescent light microscope, with a differential 
uptake of fluorescent DNA binding dye (AO/EB dye mix). Acridine orange (AO) 
permeates all cells and makes the nuclei appear green, while ethidium bromide (EB) is 
taken up only by cells that have lost cytoplasmic membrane integrity, and stains the 
nuclei red. Panel A shows images of control group cells, with most of the cells stained 
green, indicating that there is little apoptosis taking place in the control group. Panel B 
cells were treated with 50 mM ethanol, while panel C cells were treated with radiation 
(8Gy). In both panels, there is evidence of increased apoptosis because of the number of 
cells with highly condensed red/orange nuclei. Panel D cells were exposed to 50 mM 
ethanol, followed by radiation (8 Gy). There is a significantly elevated level of apoptosis 
in this group as compared to both the control and the single agent exposure groups, as 
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evidenced by the number of red/orange-stained cells with highly condensed chromatin 
matter. 
 
      
   
    
B) EtOH (50 mM)    
   
 
 
Figure 2.9. Morphological changes in different treatment groups of HepG2 cells.  
The cells were treated as described in the method section, washed with cold PBS, and 
stained with AO/EB dye mixture, and then observed using a fluorescent microscope 
(original magnification 400x). (A) Microphotograph of blank control HepG2 cells, 
incubated with the media only. The normal non-apoptotic cells were dyed green, while 
apoptotic cells, with highly condensed chromatin material, were dyed red with the 
AO/EB dye mixture. (B) HepG2 cells treated with 50 mM ethanol. There are more 
apoptotic cells compared to the control group. (C) HepG2 cells exposed to radiation (8 
Gy). The number of apoptotic cells is comparable to that in the ethanol treated group, but 
significantly higher than the number in the control group. (D) The group treated with 50 
mM ethanol for 24 h, then exposed to radiation (8 Gy). The number of apoptotic cells is 
A) Control     
C) XRT (8Gy)    D) EtOH (50 mM) + XRT (8Gy) 
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higher than that in both the control and the single agent treatment groups. Apoptosis was 






This investigation reports on the in vitro assessment of the toxic effects of ethanol 
and ionizing radiation on HepG2 cells by m vels and antioxidant 
enzyme activities. Consumption of ethanol is widespread and many cancer patients who 
undergo radiotherapy have consumed ethanol at one time or another. In a majority of 
cases, it has been assumed that consumption of ethanol will not affect the outcome of 
radiotherapy, in spite of the well known fact that both ethanol and radiation produce free 
radicals that can be very damaging to tissues. Radiation oncologists who administer 
radiotherapy are, for the most part, not aware that significant alcohol consumption is a 
ts. 
ost investigations on the effects of ethanol and radiation on biological systems have 
ethanol, followed by ionizing radiation in a model system, such as HepG2 cells. The aim 
of this investigation was to determine the mechanism of toxicity of combined exposure to 
 radiation, and show that the toxicity of ethanol enhances the toxicity 
easuring antioxidant  le
possible predisposing conditions that could potentially endanger the lives of patien
M
focused on single agent treatments. A few combined exposure studies have been reported, 
including tobacco and radiation [82], but most investigations have concentrated on 
radiation and other chemical agents [83-85].  Moreover, the end points measured in these 
studies were biological or clinical outcomes such as radiosensitization, radiation 
protection or tumor induction, not antioxidant status.  





t al. [88]. Devi et al. reported that 
exposu
the protein sulfhydryl group, producing mixed disulfide. Under such 
zing radiation in vitro. Linear decreases in GSH levels with increases in ethanol 
concentrations and radiation doses were established, leading to the choice of an ethanol 
concentration of 50 mM and a radiation dose of 8 Gy to be used for the rest of the 
experiments.  
2.5.1. Effects of Combined Exposure on GSH Levels. The results showed that 
the levels of GSH in HepG2 cells exposed to ethanol followed by ionizing radiation were 
significantly lower than GSH levels in cells exposed to ethanol or radiation only. GSH is 
present in all mammalian cells and is a powerful antioxidant that scavenges free radicals 
and hydrogen peroxide, and neutralizes toxic metabolites by condensing with them both 
enzymatically and nonenzymatically [86]. GSH is found in both the cytosol and 
mitochondria of cells. Most ROS are formed in the mitochondria during tissue respiration 
as a result of leakage of electrons through the mitochondrial electron transport chain. 
Neuman et al. have reported a dramatic decrease in mitochondrial GSH in isolated 
hepatocytes exposed to alcohol [87]. Cytotoxicity of ethanol has been attributed to GSH 
depletion according to studies conducted by Hirano e
re of rat hepatocytes to ethanol increased ROS production, decreased GSH, and 
increased lipid peroxidation [89].  Incubation of HepG2 cells with ethanol induces 
oxidative stress and leaves the cells vulnerable to further injury by ROS. When cells are 
exposed to ionizing radiation after ethanol exposure, they are not able to cope with 
elevated levels of ROS. In conditions of severe oxidative stress, the ability of the cells to 
reduce GSSG to GSH is overcome, leading to GSSG accumulation within the cytosol. To 





produced by ethanol metabolism and ionizing radiation is metabolized by GSH 
stances, GSH is not regenerated; thus depletion of cellular GSH can be potentiated 
by severe oxidative stress [90]. This explains the significant decreases in the GSH levels 
in the combined exposure groups as compared to single agent exposure, suggesting that 
exposure to ethanol enhances the toxicity  of ionizing radiation through hightened 
oxidative stress. 
2.5.2. MDA Levels. Significantly higher levels of MDA were identified in the 
HepG2 cells in the combined exposure groups as compared to both the control and the 
single agent exposure groups.  MDA is a marker of lipid peroxidation [91] and there are 
numerous reports on induction of lipid peroxidation by both ethanol and radiation [92-
95]. The free radicals produced by irradiation attack on polyunsaturated fatty acids 
(PUFA) leads to the formation of MDA, along with other products. Ethanol increases the 
levels of CYP2E1 by a post-transcriptional mechanism, leading to the formation of stable 
adducts. During its catalytic cycle, CYP2E1, which has high NADPH oxidase activity 
[96], generates ROS and hydrogen peroxide, and in the presence of iron, Fenton reaction 
takes place, producing more harmful free radicals such as hydroxyl radicals, ferryl 
species, and 1-hydroxyethyl radicals. These ROS damage the cell membranes through 
lipid peroxidation and the production of lipid aldehydes such as MDA and 4-
hydroxynonenal. Increased levels of MDA is an indicator  of  elevated toxicity. 
2.5.3. GR and Caspase-3 Activities. Levels of glutathione reductase and 
caspase-3 activities were more elevated in the combined exposure groups than those in 
the single agent treatment groups. Previous investigations have reported that both ethanol 
and radiation increase the activities of these enzymes [97-101]. The hydrogen peroxide 
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peroxidase (GPx) in the cytosol and by catalase in the peroxisomes. Metabolism of 




back to GSH, at the expense of NADPH, to restore the cells’ redox status. Under 
conditions of elevated levels of ROS, more GSH is consumed and considerable GSSG is 
produced. The activity of GR increases to cope with the enormous amount of GSSG 
being produced. Changes in the levels of caspase-3 are discussed further under detection 
of apoptosis by EB/AO staining. 
2.5.4. Catalase Activity. The results showed significant decreases in catalase 
activity in all treatment groups, as compared to the control groups. Additionally, the 
combined exposure groups had significantly lower catalase activity than that in the single 
agent exposure groups. This is in agreement with findings of previous investigations 
which have reported decreases in catalase activity, due to exposure to ethanol and 
ionizing radiation [102-105], and inactivation of catalase by superoxide radical [106]. 
Lipid peroxidation has been shown to damage membrane proteins, inactivating receptors 
and enzymes. These observations are supported by the in vitro catalase activit
vated levels of ROS in the combined exposure groups produce the greatest toxic 
effects on the catalase enzyme. 
2.5.5. MTS Assay. The cell viability of HepG2 cells was reduced to the lowest 
level in the combined exposure groups as compared to the control, and significantly 
lower as compared to the single agent exposure groups. Previous studies have shown that 
ethanol and radiation reduce cell viability [107-109]. The deleterious changes produced 
by ROS in essential biomolecules (such as DNA, lipids, and proteins) in the cells 
eventually lead to cell death, reducing cell viability. ROS induce oxidative damage to 
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DNA, which suffers double and single strand breaks, deoxyribose damage, and base 
modifications. The proteins and lipids undergo oxidation, forming lipid aldehydes (such 
as MDA) and oxidized proteins. These alterations affect vital cellular functions and lead 
to cell death. Our investigation showed that combined exposure has a greater toxic effect 
on cell 
ual α-carboxyl group. This amino acid linkage prevents 
degrada
viability than single agent exposure does. 
2.5.6. Cysteine Levels. The results of this investigation showed that CYS levels 
significantly increased in the combined exposure group, but remained unchanged in the 
radiation only group as compared to the control, and decreased significantly in the 
ethanol only group. Increases in CYS levels could have resulted from the degradation of 
GSH by the ectoenzyme, γ-glutamyltranspeptidase (GGT), located on the external surface 
of certain cells. Degradation of GSH by GGT yields cysteinylglycine, which is broken 
down by dipeptidase to produce CYS and glycine. The amino acid linkage in GSH is 
such that glutamate and CYS are linked by a peptide bond through the γ-carboxyl group 
of glutamate, instead of the us
tion of GSH by intracellular peptidases. The only enzyme capable of degrading 
GSH is the extracellular enzyme, GGT [110]. Under normal conditions, GSH is 
transported out of a cell by carrier-mediated transporters [111],  across the cell 
membrane, to participate in the γ-glutamyl cycle for the regeneration of CYS. When 
oxidative stress sets in, however, the cell membrane is destroyed through lipid 
peroxidation and protein oxidation, releasing the cellular contents, including GSH.  
2.5.7. Detection of Apoptosis by EB/AO Staining. Significantly more HepG2 
cells were stained red/orange with EB/AO staining in the combined exposure groups than 
there were in the single agent exposure groups or the control. Apoptotic cells have 
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condensed or fragmented chromatin, which stain red/orange with EB/AO, while live cells 
have normal nuclei with organized chromatin and stain green [112-113]. Damage to 
mitoch
2.6. CONCLUSION 
The results of this investigation have shown that combined exposure of HepG2 
cells to ethanol and ionizing radiation has a significantly greater toxic effect on cells than 
single agent exposure does. Since both ethanol and ionizing radiation have been proven 
to produce free radicals in biochemical environments, it seems reasonable to suggest that 
pre-radiation exposure of cells to ethanol induces oxidative stress in the cells, and leaves 
them vulnerable to further attacks by ROS. When these cells are later exposed to ionizing 
radiation, the antioxidant defense system is not able to withstand the renewed onslaught 
of ROS, and more oxidative damage results. Therefore, it is concluded that a possible 
ondrial membrane by ROS produced by both ethanol and ionizing radiation leads 
to the releases of cytochrome c molecules from the mitochondria into the cytosol. 
Proapoptotic enzymes, caspases, are activated by cytochrome c in the cytosol to trigger 
the apoptotic process [114]. Studies have shown that decreases in the GSH levels in cells 
triggers apoptosis. Another mechanism of apoptosis induction is the involvement of Fas 
and Fas ligand. Fas is a receptor found on hepatocytes, and can interact with Fas ligand 
found on the surface of certain T-cells to trigger chemical processes that lead to 
apoptosis. The binding of Fas to Fas ligand to trigger the process of apoptosis is mediated 
by ROS, like those produced by ionizing radiation and ethanol metabolism [115]. In this 
investigation, combined exposure lead to greater elevated levels of apoptosis than did 





mechanism to account for enhanced toxicity of ethanol and ionizing radiation on HepG2 
cells is through increased oxidative stress. This investigation could be an eye-opener for 
doctors and oncologists to consider recent drinking histories of cancer patients before 
radiotherapy is administered. Combined exposure studies are relevant since the 
environment contains many diverse agents that can enter the biological systems, and 

























3. EFFECTS OF COMBINED EXPOSURE TO ETHANOL AND IONIZING 
 
 
RADIATION ON THE ANTIOXIDANT STATUS OF AN IN VIVO MODEL 
3.1. INTRODUCTION 
The data from the in vitro investigation showed that combined exposure to 
thanol and ionizing radiation results in significantly higher oxidative stress compared to 
ngle agent exposure [116]. Numerous investigations have shown that ethanol and 
nizing radiation can individually induce a state of oxidative stress in biological systems 
rough increased production of reactive oxygen species (ROS), such as  hydrogen 
eroxide (H2O2), hydroxyl radical (•OH), superoxide radical (O2•-), and many other types 
f ROS, proteins and lipid aldehydes [117-123]. 
 Ethanol metabolism by the enzyme cytochrome P4502E1 (CYP 2E1) is well 
ocumented to induce the production of reactive oxygen species [124-127]. This pathway 
as been identified as the central pathway by which ethanol produces free radicals and 
athological transformations that are associated with chronic ethanol intake [128-129]. 
oreover, investigators have found a positive correlation between increased levels of 
YP 2E1 and heightened deleterious changes in organs such as the liver [130]. 
dditionally, enzymatic metabolism of ethanol by alcohol dehydrogenase and 
cetaldehyde dehydrogenase enzymes result in increased levels of NADH, which induce 
the conversion of xanthine dehydrogenase (XDH) to xanthine oxidase (XO), and 
subsequent generation of free radicals [131]. Non-enzymatic metabolism of ethanol 
gener  
eroxy radical intermediate, which then undergoes rearrangement to produce 




















diation with water molecules, which 
constitu
pread use of 
tic ethanol metabolism proceed to attack cellular components such as cell 
membranes, mitochondrial membranes, and DNA, resulting in protein oxidation, lipid 
peroxidation, breaks in single and double stranded DNA, and tissue damage. 
Ionizing radiation is known to produce tissue damage through direct ionization by 
energy transfer of the atoms comprising the targeted proteins, lipids, and DNA [132]. 
Radiation-induced DNA damage has been reported in rats and mice by many 
investigators [133]. Interaction of ionizing ra
tes up to 80% of the cells in the living organisms, results in the fission of O-H 
bonds in water to produce hydrogen (H•) and hydroxyl (•OH) radicals. Hydroxyl radical 
is the most lethal of all the ROS formed from radiolysis of water molecules, and reacts at 
a diffusion-controlled rate with the majority of the molecules in the living cells [134]. It 
is commonly believed that most, if not all, of the deleterious effects of exposure to 
ionizing radiation in the living systems are initiated by the attack of  •OH on 
carbohydrates, lipids, proteins, and DNA molecules [135], resulting in loss of cell 
membrane integrity, lipid peroxidation, mitochondrial permeability transition, and 
formation of other harmful adducts such as MDA and 4- hydroxynonenal (4-HNE). 
Ethanol and ionizing radiation produce ROS in biological systems.  Exposure of 
an organism to certain levels of these agents simultaneously should be viewed as having a 
potential to cause increased pathological damage. Due to increased application of 
radiotherapeutic procedures to cancer patients, who may have other predisposing 
conditions likely to negatively impact on the outcome of radiotherapy, it has become 
necessary to engage in combined exposure studies to investigate how various agents and 






 as an alcoholic beverage, and increased exposure to ionizing radiation in 
radiotherapy situations, combined exposure investigations have not been performed.  The 
use of ethanol in the context of chronic heavy and light drinking, followed by exposure to 
ionizing radiation, would model a cancer patient with a chronic heavy drinking recent 
history undergoing radiotherapy. Furthermore, it is well documented that the risk of 
serious complications following therapeutic irradiation is heightened by a variety of 
predisposing conditions, including diabetes, ataxia telangiectasia, prior abdominal/pelvic 
surgeries, and collagen vascular diseases such as scleroderma or lupus [136-139].   
In this investigation the CD-1 mice were used to model chronic light and heavy 
drinking followed by exposure to a sub-lethal dose of ionizing radiation, as would be the 
case in a chronic alcohol user who undergoes therapeutic irradiation. The mice were 
chronically exposed to low-dose (5%) ethanol or high-dose (10%) ethanol in their 
drinking water for 6 weeks, followed by exposure to 8 Gy of ionizing radiation, b
acrificed 4 d later. To assess the effects of combined exposure on the mice, 
various parameters were measured, including total blood count, GSH, CYS, GSSG, and 
MDA levels, and the antioxidant activities of the enzymes catalase and glutathione 
reductase. 
 
3.2. EXPERIMENTAL DESIGN 
      3.2.1. Chronic Light Ethanol Treatment. The animals in this group received 
ethanol in increasing concentrations, to a final concentration of 5% (v/v) ethanol solution 
as their sole drinking fluid for 6 weeks. 
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3.2.2. Chronic Heavy Ethanol Treatment. The chronic high dose ethanol group 
received ethanol in increasing concentrations to a final concentration of 10% (v/v) 
ethanol solution as their sole drinking fluid. The ethanol treatment period lasted 6 weeks. 
3.2.3. Exposure to Ionizing Radiation. The animals in the combined exposure 
and radiation only groups were exposed to ionizing radiation in the middle of the 6 weeks 
of treat
3.3. MATERIALS AND METHODS 
3.3.1. Materials. HPLC-grade acetonitrile, glacial acetic acid, water, and 
phosphoric acid, used for the preparation of the mobile phase, were purchased from 
Fisher Scientific (Fair Lawn, NJ USA). N-(1-pyrenyl)-maleimide (NPM), used as a 
derivatizing agent for measurement of CYS and GSH, 1,1,3,3-tetramethoxypropane, and 
ethanol were purchased from Aldrich (Milwaukee, WI USA). Protein concentration was 
evaluated with the Bradford reagent obtained from BioRad (Melville, NY USA). The 
CD-1 mice were from our breeding colony (VA Medical Center, St Louis, MO USA). 
Heparin was provided by Dr. Mark Ranney (University of MO-Rolla).  Safety syringes 
were purchased from Fisher Scientific (Fair Lawn, NJ USA). 
ment, as detailed under the material and methods section. 
3.2.4. Oxidative Stress Studies. The antioxidant status of the animals was 
determined by measuring the GSH, CYS, and GSSG levels, along with the activities of 
some antioxidant enzymes (GR and CAT). MDA, which is a lipid peroxidation 
biomarker, was also measured. The aim of these procedures was to determine how the 






3.3.2. Animals. The mice were housed in a temperature-controlled (25oC) room, 
that was equipped to maintain a 12 h light-dark cycle. Tap water and standard rat chow 
(Purina rat chow) were given ad libitum for 3 weeks while the mice were being 
acclima
ing (10% v/v ethanol solution as the sole drinking fluid); Group IV (XRT) 
=7): Radiation only (8 Gy XRT); Group V (L-EtOH + XRT) (n=7): Chronic low-dose 
thanol drinking (5% v/v ethanol solution) and 8 Gy XRT; Group VI (H-EtOH + XRT) 
(n=7): Chronic high-dose drinking (10% v/v ethanol solution) and 8 Gy XRT. The same 
treatments were continued after the mice were irradiated until the day of sacrifice. All of 
the procedures performed with the animals were approved by the University of Missouri 
– Rolla Animal Care and Use Committee 
3.3.3. Exposure of Animals to Ethanol. The control group mice were kept for 
the same period as the treatment groups, but were fed only the mouse food and tap water. 
The chronic low-dose ethanol drinking groups received 2% (v/v) ethanol solution diluted 
from 99.8% ethanol as their only drinking fluid for 3 days, followed by a 4% ethanol 
solution (v/v) for 4 days. Finally, a 5% (v/v) ethanol solution was provided for the next 5 
weeks to complete the chronic drinking treatment period. The chronic high-dose ethanol 
drinking treatment groups received a 2% (v/v) ethanol solution as their only drinking 
fluid for 3 days, followed by 4% for the next 3 days, 6 % for 3 days, and 8 % for another 
ted before the experiments began. 40 mice were randomly divided into six groups 
(6 or 7 animals per group), and housed 3 or 4 per cage in polycarbonate cages with 
wooden chips as bedding. The groups were designated as follows: Group I (n=6): Control 
(no exposure to ethanol or XRT); Group II (L-EtOH) (n=6): Chronic low-dose ethanol 






5 days. Finally, a 10 % (v/v) ethanol solution was provided for the next 4 weeks to 
complete the chronic drinking treatment period. 3 % (w/v) food grade white sugar was 
added to the drinking fluids of both the control and the treatment groups to improve the 
palatability of the ethanol solutions. The average peak ethanol intake was 5.4g/kg body 
weight for the chronic low-dose ethanol drinking groups, and 11.2g/kg body weight for 
the chronic heavy ethanol drinking groups. 
3.3.4. Exposure of Animals to Ionizing Radiation. At the end of the ethanol 
treatment period, the mice in the combined exposure groups and the radiation only groups 
were exposed to radiation. The animals were exposed to 8 Gy of radiation at a dose rate 
of 3 Gy/min using a 9 MeV beam generated by a Varian Linear accelerator, model 21 EX 
(Varian Associates, Walnut Creek, CA, USA), at the Radiation Oncology Department of 
the Phelps County Regional Medical Center in Rolla, Missouri, USA. A 25 x 25 cm field 
was used, and output factors were checked once a week. Flatness of the field was also 
checked once a week and was maintained within 2 %. A 25 x 25 cm field showed the 
90% isodose at 2.75 cm depth. The 95% fall-off point was at 2.5 to 2.6 cm depth. Less 
than 10% dose variation through the thickness of a mouse was achieved under these 
conditions. All of the animals were anesthetized and heparinized blood was collected via 
cardiac puncture 4 days after radiation treatment. After perfusion with an antioxidant 
buffer, the livers were removed. The blood samples were kept on ice or at 4-8oC, and 
taken to the University of Missouri-Columbia, Research Animal Diagnostic Laboratory 
(RADIL) the very next day for complete blood count analysis. The liver tissue samples 
were analyzed immediately for GSH, CYS, and GSSG levels and the remaining samples 
were kept in a -80 oC freezer for later analysis. 
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3.3.5. Preparation of Tissue Homogenates. The tissue samples from the livers, 
kidneys, and brains of the mice were homogenized (0.15 g/ml) in antioxidant buffer to 
avoid oxidation. The antioxidant buffer was prepared by dissolving 1.2 g disodium 
phosph
L of a 2 units/ml glutathione reductase 
enzyme
ate, 0.32 g sodium dihydrogen phosphate, 100 µL butylated hydroxytoluene 
(BHT) solution (0.1102 g BHT in 1 mL 100 % ethanol), 0.841 g aminotriazole, 0.039 g 
DETAPAC, and 0.065 g sodium azide in 1 L HPLC-grade water. 
3.3.6. Determination GSH and CYS. Tissue levels of GSH and CYS were 
determined by RP-HPLC, according to the method developed  by Winters (Winters et al., 
1995). The HPLC system (Thermo Electron Corporation) consisted of a Finnigan Spectra 
System vacuum membrane degasser (model SCM1000), gradient pump (model P2000), 
autosampler (model AS3000), and fluorescence detector (model FL3000) with λex = 
330nm and λem = 376nm. The HPLC column was a Reliasil ODS-1 C18 column (5 µm 
packing material) with 250 x 4.6 mm (Column Engineering, Ontario, CA, USA). The 
mobile phase was 70% acetonitrile and 30% water and was adjusted to a pH of 2 with 
acetic acid and o-phosphoric acid. The NPM derivatives of CYS and GSH were eluted 
from the column isocratically at a flow rate of 1mL/min. 
3.3.7. Determination of Oxidized Glutathione (GSSG). Straight tissue 
homogenate (84 µL) was mixed with 16 µL of 2-vinyl pyridine and incubated for 1 h at 
room temperature to block the preexisting GSH. At the end of the incubation period, 95 
µL of 2 mg/ml solution of NADPH and 5 µ
 were added to the tissue homogenate and mixed. An aliquot (100 µL) of this 
mixture was removed and mixed with 150 µL of HPLC grade water and 750 µL of NPM 
(1 mM in acetonitrile). This mixture was incubated for 5 min at room temperature, after 
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which 5 µL of 2N HCl was added to stop the reaction. The samples were filtered into 
vials through 0.2 µm filters and injected into the HPLC system. 
3.3.8. Determination of Malondialdehyde (MDA). The MDA determination 
was do
0.6% tetrahydrofuran. 
vity was calculated from 
ne by the RP-HPLC method using λex = 515 nm; the λem 550 nm (Gutteridge, 
1975). Tissue homogenate (350 µL) was mixed with butylated hydroxytoluene (BHT) 
(100 µL of 500 ppm solution) and 10% trichloroacetic acid (550 µL), and boiled for 30 
min. After the solution was cooled on ice and centrifuged for 10 min at 1500 xg, the 
supernatant (500 µL) was mixed with thiobarbituric acid (500 µL). The tubes were boiled 
again for 30 min, and then cooled on ice.  A solution (500 µL) was added to n-butanol 
(1.0 ml), vortexed, and centrifuged for 5 min at 60 xg to facilitate a phase separation. The 
top layer was then filtered through 0.2 μm filters and injected onto a 5 μm C18 column 
(250 x 4.6 mm) on a RP- HPLC system. The mobile phase consisted of 69.4% 5mM 
sodium phosphate buffer pH = 7.0, 30% acetonitrile, and 
3.3.9. Glutathione Reductase (GR) Activity Determination. Glutathione 
reductase (GR; EC 1.6.4.2) activity was measured spectrophotometrically at 340 nm 
following the decrease of NADPH using a commercial kit from OxisResearch™ 
(Portland, Oregon, USA). This reaction maintains the normal levels of cellular 
glutathione, essential for keeping the levels of free radicals and organic peroxides down. 
3.3.10. Catalase (CAT) Activity Determination. The activity of catalase (CAT; 
EC 1.11.1.6) in the cell homogenates was measured spectrophotometrically at 240 nm 
following the exponential disappearance of hydrogen peroxide (H2O2; 10 mM) according 








 considered significant. 
 
initial e-kt where k, is the rate constant, Ainitial , is the initial absorbance, and A60 is 
the absorbance at 60 s. 
3.3.11. Total Blood Count. Immediately following blood collection, with a 23 g 
needle into a heparinized syringe, peripheral blood smears were made on microscope 
slides, according to the standard operating procedure set by the Research Animal 
Diagnostic laboratory (RADIL) of the University of Missouri-Columbia, USA. 500 µL of 
whole blood in Ependorf tubes on ice, together with the blood smears, were taken to MU 
RADIL for complete blood count analysis. All of the red blood cell and platelet 
parameters were measured by an automated hematology instrument (Abbott Cell-Dyn 
3500 Hematology analyzer, Abbott Labs., Abbott Park, IL, USA). White blood cell 
counts, including a differential count, were also measured. White blood cell dif
btained from blood smears prepared at the time of blood collection. 
3.3.12. Protein Determination. A Hitachi U-2000 double beam UV-Vis 
spectrophotometer (Tokyo, Japan) was used to measure protein concentration using the 
Bradford assay (Bradford, 1976) and antioxidant enzyme activities. 
3.3.13. Statistical Analysis. Means are reported with their standard deviations. The
were analyzed with the student’s t-test when only two means were compared and 
by one-way analysis of variance (one-way ANOVA) to assess the significance of the 
difference between the control and the treatment groups, and between the single agent 
exposure and combined exposure groups. Calibration curves were plotted and linear 
equations from the calibration standards were used to determine the parameters to be 





 VIVO RESULTS 
3.4.1. Weight Changes During the Treatment Period. The mice were weighed 
on a weekly basis to monitor changes in weight in each group. The results of the weight 
changes are shown in Figures 3.1 to 3.6. There were increases in weight in all the groups 
during the 41 d treatment period, but the control group had the most steady weight 
increase, and higher weight gain as compared to the rest of the groups. All the ethanol 
treatment groups had similar patterns in weight fluctuations, and comparable weight 
changes. There was a drop in the weight of the mice in all the groups that were irradiated, 































a steady increase in weight  in all the mice in the control group. (C: control, C1, C2, C3, 
 
 
ce were kept for 6 weeks, and were provided food and water ad libitum. There was 




























Figure 3.2. Weight changes in mice treated with light/low-dose ethanol.  
The mice were provided the ethanol (5% v/v) solution as their only drinking fluid, and 
rodent food ad libitum. There were fluctuations in weight during the treatment period, but 
the general trend was a gradual increase. (L: light/low-dose ethanol treatment, L1, L2, L3, 


























gh-dose ethanol group.  
 
Figure 3.3. Weight change in the heavy/hi
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The mice in this group were given ethanol solution at a final concentration of 10 % (v/v), 
nd the treatment lasted 6 weeks. There were fluctuations in weght during the treatment 
period, but the trend was a gradual increase. (H: heavy/high-dose ethanol treatment, 






























Figure 3.4. Weight changes in the mice of the radiation only group. 
ice were provided food and water ad libitum for six weeks, and were exposed to 8 
Gy of ionizing radiation on the 38th day. There was a steady increase in weight up to the 
38th day, but the weight dropped sharply after the exposure to radiation. (X: radiation 
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Figure 3.5. Weight changes in light/ low-dose ethanol and radiation group. 
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The entire treatment period was 6 weeks (42 d). Food and ethanol solution (5% v/v), as 
the only drinking fluid, were given ad libitum. There were fluctuations in weight, but the 
end was that of a gradual increase up to the 38th day, then the weight dropped. (LX: 
light/low-dose ethanol + XRT, LX1-LX7 represent all the animals in the light/low-dose 





























Figure 3.6. Weight changes in heavy/high-dose ethanol combined exposure group. 
 The mice were given ethanol solution at a final concentration of 10 % (v/v) as their only 
drinking fluid, and rodent chow ad libitum for 38 days, then exposed to 8 Gy of ionizing 
radiation. There were fluctuations in weight, but the general trend was that of an increase 
up to the 38th day, followed by a decrease. (HX: heavy/high-dose ethanol + XRT 




in each of the experimental groups are shown in Figure 3.7. The weight gain percentage 
 
 
3.4.2. Percentage Weight Gain up to the 38th Day. The percentage weight gain 
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was determined by subtracting the initial weight of each animal from the weight on the 
th38  day, and expressing the difference as a percentage. The control group had a slightly 
higher weight gain than the rest of the groups, but the difference was not significant. The 



































Figure 3.7. Percentage weight gain in grams in each group up to the 38th day.  
There were weight gains in each group, which averaged 10 to 15 grams. The control 
group gained a little more weight than the ethanol treatment groups. The percentage 
weight gains in all the ethanol treatment groups were not significantly different. (H-
EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose ethanol 
treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH + 





3.4.3. Daily Fluid Intake. The average daily fluid in take of the mice during the 
treatment period are shown in Figures 3.8 to 3.11. There were fluctuations within a 
narrow range in the daily fluid intake of the mice in all the groups. The control group had 
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a slightly higher fluid intake than the ethanol treatment groups. The light/low-dose 
ethanol groups had slightly higher, but insignificant fluid intake as compared to the 
























Figure 3.8. Daily fluid intake for the control group.  
The fluid intake was measured after every 24 h for 41 d. The volume taken by each 
mouse in the control group fluctuated within a narrow range. The control group had 


























Figure 3.9. Daily fluid intake for the light/ low-dose ethanol treatment group. 
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 The volume of drink was measured after every 24 h. The mice were provided ethanol 
narrow range. 


























Figure 3.10. Daily fluid in take for the mice in heavy/high-dose ethanol group.  
The mice were provided ethanol solution (10 % v/v) as their only drinking fluid. The 
mice in this group had the lowest fluid in take, but the difference was insignificant 




























Figure 3.11. Daily fluid intake for the mice in the radiation only group.  
Water was provided ad libitum, and the volume of drink was measured after every 24 h. 




3.4.4. Complete Blood Count Results. Table 3.1 displays the protein content and 
the white blood cell parameters (WBC numbers, neutrophils, lymphocytes, monocytes, 
eosinophils, and basophils) obtained from manual differential data using the blood smears 
that were prepared from the blood of the mice immediately after sacrifice. The protein 
content of the blood was significantly higher in the control group than that in both the 
single agent and combined exposure groups. The combined exposure groups had lower 
protein content as compared to the single agent exposure groups, except for the XRT 
group, which had the lowest protein content. The number of white blood cells (WBC) 
as significantly higher in the control compared to the single agent and combined 
ose ethanol groups had the same numbers of neutrophils, while the low-dose ethanol and 
XRT groups had the lowest number. The numbers of neutrophils in the high-dose ethanol 
combined exposure and XRT only groups were too few to be determined. The numbers 
of lymphocytes, monocytes, and eosinophils in the high-dose ethanol combined exposure 
and XRT only groups were too few to be determined, while the control had the highest 
numbers and the low-dose ethanol combined exposure had the lowest. The high-dose 
ethanol group seemed to deviate from this trend, with numbers closer to those of the 
control. The number of basophils was significantly higher in the control, as compared to 
bined exposure 
The red blood cell and platelet parameters (RBC numbers, hemoglobin content, 
hematocrit %, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), 
w
exposure groups, with the exception of the high-dose ethanol group. The high-dose 
ethanol combined exposure group had the lowest number of WBC.  The control and high-
d
that of the single agent and the combined exposure groups. The com
groups had the lowest numbers of basophils. 
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µL) (x1.0+03/ µL) 
pro (x1.0+03/ (x1.0+03/ s (x1.0+03/ (x1.0+03/ (x1.0+03/ Basophils 
Normal 5.9 - 
range 10.3 5.0 - 13.7 N/A N/A N/A N/A 0.0 - 0.2 
Control 6.3 ± 0.3 3.4 ± 1.0 0.4 ± 0.2 3.0 ± 0.8 0.08 0.007 0.19 ± 0.03 
L-EtOH 6.2 ± 0.8 1.0 ± 0.6*/** 0.2 ± 0.1* 0.9 ± 0.4* 0.06 0.02 0.04 ± 0.006*/** 
L-EtOH 
H-EtOH 
+ XRT 5.5 ± 0.5 0.2 ± 0.06* 0.0000 0.000 0.000 0.00 0.01 ± 0.0 
0.05 ± 
H-EtOH 5.8 ± 0.6 3.9 ± 1.0** 0.4 ± 0.08 3.4 ± 0.9 0.12± 0.09  0.03 0.15 ± 0.08** 
XRT 5.0 ± 0.9 0.3 ± 0.2* 0.0000 0.000 0.000 0.00 0.013 ± 0.005 




mean corpuscular hemoglobin concentration (MCHC), platelet numbers, and mean 
platelet volume (MPV)) were obtained from automated differential data, which was 
acquired on a Cell Dyne 3500 (Abbot) analyzer, are displayed in Table 3.2. The RBC 
numbers, hemoglobin content, and hematocrit percentage were highest in the ethanol 
only treatment groups, but lowest in the XRT only group. Nevertheless, all of these 
parameters fell within the normal range in all the groups. The MCV and MCH were slow-
dosely higher in the control, but not significant when compared to the treatment groups; 
the me
 
but they were too 
few to be counted in the high-dose ethanol combined exposure group. The MPV values 
fell within the normal range in all of the groups, and were not significantly different from 
asurements for these parameters fell within the normal range in all of the groups. 
There was no significant difference in MCHC in all of the groups. The number of
platelets was highest in the control and lowest in the XRT only group, 
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Ta .2 s l an  on r od ce amete





3/ µL) MPV (fL) 
ach oth  valu




range 9.42 15.1 45.4 
45.4 - 




2972 5.0 - 20.0 
6.36 - 11.0 - 35.1 - 
Control 8.9 ± 0.6 14.8 ± 0.7 44.5 ± 1.9 51.2 ± 0.9 16.6 ± 0.4 32.4 ± 0.7 960 ± 25 9.5 ± 1.2 
L-EtOH 9.9 ± 0.7 15.8 ± 1.1 48.3 ± 4.0 49.2 ± 0.7 15.9 ± 0.2 32.3 ± 0.5  768 7.7 ± 0.4 
12.4 ± 37.2 ± 692 ± 
L-EtOH 
H-EtOH 10.4 ± 0.7 15.6 ± 0.6 48.7 ± 2.9 47.5 ±1.0 15.05 ± 0.5 31.8 ± 0.7 952 ± 92 8.9 ± 2.3 
XRT 7.7 ± 0.7 0.9* 3.8*/** 48.8 ± 0.9 16.07 ± 0.4 32.9 ± 1.4 36* 8.1 ± 1.6 
+ XRT 8.9 ± 0.8 14.2 ± 1.3 43.0 ± 4.9 48.6 ± 1.3 16.0 ± 1.7 32.9 ± 0.7 787 9.7 ± 1.0 
H-EtOH 
+ XRT 9.2 ± 0.6 14.2 ± 1.1 44.0 ± 3.6 48.2 ± 1.4 15.4 ± 0.2 31.8 ± 0.6 0.00 0.00 
 
All of the red blood cell and platelet parameters were measured by an automated 
hematology instrument (Abbott Cell-Dyn 3500 Hematology analyzer) at the UMC 
Research Animal Diagnostic Laboratory (RADIL), Columbia, MO, USA. The number of 
platelets and MPV could not be determined in the high-dose ethanol combined exposure 





3.4.5. Liver GSH Levels. The GSH levels in all the groups were determined 
following homogenization of the liver tissue samples, and derivatization using NPM. 
Figure 3.12 shows how the levels of GSH varied in the livers of mice that were treated 
with low-dose ethanol and/or radiation. The GSH levels were highest in the control 
group, and lowest in the combined exposure group (group treated with ethanol plus 
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radiation exposure). The combined exposure group had significantly lower GSH levels 
ompared to the single agent exposure groups. The results for the GSH levels of high-
e GSH levels in this 
figure followed a pattern similar to that in Figure 3.5 (a), but the differences were larger. 
Chronic high-dose ethanol com
lower GSH levels than chronic low-dose ethanol combined with radiation exposure. In 
both of these groups, combined exposure resulted in significantly lower GSH levels than 
the control and single agent exposure groups. The high-dose ethanol combined exposure 
group resulted in significantly lower GSH levels compared to low-dose ethanol combined 
exposure group. The sample chromatogram  
liver samp
allest in the high-dose ethanol combined exposure group. 
c
dose ethanol combined exposure groups are shown in Figure 3.13. Th
bined with radiation exposure resulted in significantly 
s shown in Figures 3.14 to 3.19 are from the










































Figure 3.12. GSH levels in the chronic low-dose ethanol groups (liver). 
radiation. The GSH levels were measured by the HPLC method after homogenization of 
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the liver tissue samples and derivatization with NPM. The GSH levels were significantly 
had a significantly lower GSH level as compared to the single agent treatment groups. 
lower in the treatment groups as compared to the control. The combined exposure group 
Significantly different compared to control (p < 0.05). Significantly different compared 
group, L-EtOH: light/low-dose ethanol treatment group, H-EtOH + XRT: high-dose 
XRT: radiation only group, pr: protein) 
* 
# 
to combined exposure group (p < 0.05). (H-EtOH: heavy/high-dose ethanol treatment 

































Figure 3.13. GSH levels in the high-dose ethanol groups (liver).  
The mice were treated with ethanol (10 %v/v) for 5 weeks, and then exposed to 8 Gy 
radiation. The GSH levels were measured as described above. The combined exposure 
group had significantly lower GSH levels as compared to the control and single agent 
exposure groups. (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-
dose ethanol treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-










































    
 
 
Figure 3.14. The control liver sample Chromatogram.  
The animals in the control group were not exposed to ethanol or radiation. Food and tap 
water was provided ad libitum. Separation conditions: An ODS-1 C18 Column (5 µm 
packing material) with 250 x 4.6 mm (i.d) was used for the separation. The NPM 
derivatives were measured by a fluorescence detector (λex = 330 nm and λem = 376 nm). 
Flow rate was 1ml/min.The GSH peak at a retention time of 8.20 min was the highest, 
and the CYS peak was at the retention time of 10.73 min. The hydrolysis peak (due to 






































Figure 3.15. The light/low-dose ethanol group liver sample Chromatogram.  


































    
 
 
Figure 3.16. The high-dose ethanol group liver sample Chromatogram. 







































igure .17. The radiation only group liver sample chromatogram.  
 radiation at 
F 3
The mice received the same treatment as the control, but were exposed to the
































    
 
igure 3.18. The light-dose ethanol combined exposure group chromatogram (liver). 


































    
 
 
Figure 3.19. The high-dose ethanol combined exposure group chromatogram (liver). 
The separation conditions were the same as described in Figure 3.14. 
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3.4.6. Brain GSH Levels. The results of the brain GSH levels displayed in 
Figures 3.20  and 3.21, show that the control group had the highest GSH level; while 
high-dose ethanol combined exposure group had the lowest GSH levels. The single agent 
treatment groups had significantly higher GSH levels than the combined exposure 
groups. The GSH levels in the liver were significantly higher than the GSH levels in the 
































Figure 3.20. The GSH levels in the chronic low-dose ethanol groups (brain). 
The treatment of the mice and GSH determinations were done as described in Figure 3.5. 
(a).  (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose ethanol 
treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH + 






































Figure 3.21. The GSH levels in the chronic high-dose ethanol groups (brain). 
The treatment of the mice and GSH determinations were done as described in Figure 3.5. 
(b). (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose ethanol 
treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH + 





3.4.7. Liver cysteine levels. The results of the liver cysteine levels are shown 
Figures 3.22 and 23. The cysteine levels in the chronic low-dose ethanol only group 
(Group II) were the highest, whereas the high-dose ethanol combined exposure group 
(Group VI) had the lowest CYS levels. Combined exposure groups (Groups V and VI) 
 II, III, and had significantly lower cysteine levels compared to the single agent (Groups
IV) exposure and control groups. The high-dose ethanol only group had similar CYS 



































Figure 3.22. The liver CYS levels in low-dose ethanol groups.  
The treatment of the mice and CYS determinations were done as described in Figure 
3.12. (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose 
thanol treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH 
protein) 
e



























The treatment of the mice a
1
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Figure 3.23. The liver CYS levels in high-dose ethanol groups. 
nd CYS determinations were done as described in Figure 
3.12. (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose 
ethanol treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH 




3.4.8. Brain and Kidney Cysteine Levels. The kidney and brain CYS levels are 
displayed in Table 3.3. There was no consistent pattern in CYS levels in the kidney, 
while the CYS levels in the brain decreased gradual from the control, which had the 
highest level, to the high-dose ethanol combined exposure group, which had the lowest 
CYS levels.  
 
 
Table 3.3. The kidney and brain CYS levels. 
GROUPS Kidney CYS (nmol/mg pro) Brain CYS (nmol/mg pro) 
Control 8.4  ± 0.4 8.1 ± 1.2 
L-EtOH 9.4  ± 1.7* 7.4  ± 1.9*/# 
 H-EtOH  6.7  ± 1.1*/# 6.8  ± 1.4*/# 
XRT 9.1  ± 1.2*/# 6.7  ± 1.3*/# 
L-EtOH + XRT 9.3  ± 1.5* 6.0  ± 1.7* 
H-EtOH + XRT 8.1  ± 1.3 5.3  ± 1.1* 
 
The treatment procedures and CYS determinations were done as described figure 3.5. a 




3.4.9. GSSG Levels in the Liver Samples. The same liver tissue samples used to 
determine the GSH levels were derivatized and used for the determination of the GSSG 
levels. This was done in order to facilitate the determination of GSH:GSSG ratio. Figures 
 of the treatment 
xposure groups had significantly lower GSSG levels as compared to combined exposure 
3.24 and 3.25  shows the results of the GSSG levels in the two categories
groups. In both of the treatment categories, the control group had the lowest GSSG level, 




groups. The high-dose ethanol combined exposure group had significantly higher GSSG 



























Figure 3.24. The GSSG levels in the chronic low-dose ethanol groups (liver). 
The mice in this group received an ethanol solution (5% v/v) as their sole drinking fluid 
for 5 weeks, and then were irradiated and sacrificed 4 d later. The GSSG levels were 
determined by the HPLC method as described under the methods section. The control 
group h
level. (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose 







ad the lowest GSSG level, while the combined exposure group had the highest 




































Figure 3.25. The GSSG levels in the chronic high-dose ethanol groups (liver).  
The mice received an ethanol solution (10% v/v) as their sole drinking fluid. The G
level was determined as described above. The combined exposure group had the highest 
SSG level. (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose 
thanol treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH 
protein) 
SH:GSSG ratio in the liver. The control group, with the highest GSH level, and the 
lowest GSSG level, had the highest GSH:GSSG ratio as compared to the single agent and 
combined exposure groups, as can be seen in Figures 3.26 and 3.27. In the single agent 








3.4.10. GSH:GSSG Ratio in the Liver Samples. The GSH levels from the liver 




GSH:GSSG ratios, while the high-dose ethanol treatment group had the lowest ratio. The 
high-dose ethanol treatment combined exposure group had a significantly lower ratio 





















Figure 3.26. The GSH:GSSG ratio in the chronic low-dose ethanol groups (liver).  
The ratio was determined after separately determining GSH and GSSG levels, and then 
dividing the corresponding values of the two parameters. The highest GSH:GSSG ratio 






















Figure 3.27. The GSH:GSSG ratio in the chronic high-dose ethanol groups (liver). 





3.4.11. Liver MDA Levels. The high-dose ethanol combined exposure group had 
e seen 
ethanol, and XRT only groups, were not significant. High-dose ethanol resulted in higher 
MDA levels than low-dose ethanol treatment in the liver. The MDA levels in the high-
the highest MDA level, while the control group had the lowest MDA level, as can b
in Figures 3.28 and 3.29. The differences in the MDA levels of the control, low-dose 
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dose ethanol combined exposure group were significantly higher than those in the high-





































Figure 3.28. The MDA levels in the chronic low-dose ethanol groups (liver).  
The MDA levels were measured by the reversed-phase HPLC method with fluorescence 
detection. The mobile phase consisted of 69.4% 5mM sodium phosphate buffer pH = 7.0, 
30% acetonitrile, and 0.6% tetrahydrofuran. The flow rate was 1ml/min. The MDA levels 
were significantly higher in the treatment groups as compared to the control group. The 
combined exposure group had significantly higher MDA levels as compared to the single 



























Figure 3.29. The MDA levels in the chronic high-dose ethanol groups (liver). 





















3.4.12. Catalase and GR Activities in the Liver. The results for the catalase and 
glutathione reductase activities are displayed in Table 3.4. The activities of these 
enzyme were determined by a spectrophotometric enzyme assay method. The activity of 
atalase enzyme was the highest in the control group, and lowest in the high-dose ethanol 
combined exposure group. The single agent exposure groups had significantly higher 
catalase activity than the combined exposure groups. Between the combined exposure 
groups, the high-dose ethanol combined exposure group had lower catalase activity as 
compared to the low-dose ethanol combined exposure group. The glutathione reductase 
activity was the lowest in the control group, and highest in the high-dose ethanol 
combined exposure group. The single agent exposure groups had significantly lower GR 
se ethanol 
 
Table 3.4. CAT and GR activities in the liver of CD-1 mice. 
Groups CAT (units/mg pro) GR (units/mg pro) 
s 
c
activities, as compared to the combined exposure groups. The high-do
combined exposure group had significantly higher GR activity as compared to the low-
dose ethanol combined exposure group. 
 
Control 0.25  ± 0.07 23.0 ± 5.0 
L-EtOH 0.16 ± 0.02 */# 28.0 ± 3.1*/#
H-EtOH  0.13  ± 0.03*/# 32.4 ± 4.2*/#
XRT 0.15  ± 0.04*/# 39.7 ± 4.9*/#
L-EtOH + XRT 0.13  ± 0.02* 52.0 ± 6.5* 
H-EtOH + XRT 0.10  ± 0.02* 63.8 ± 5.4* 
 
d spectrophotometrically at 240 nm following the exponential disappearance 
Effects of chronic ethanol treatment followed by radiation exposure on catalase 





1984), while GR activity was measured at 340 nm following the decrease of NADPH. 




It has been shown by many investigators that oxidative stress plays a major role in 
many human pathological conditions such as cancer, diabetes, cardiovascular disease, 
neurological disorders, ischemia/reperfusion, and many other diseases as well as in aging 
[140-143]. Any agent that affects the antioxidant status of living systems, such as ethanol 
and ionizing radiation, has the potential of producing a negative impact on the health 
condition of an individual [144-146]. After the in vitro investigation showed that a 
combination of ethanol and ionizing radiation induces elevated oxidative stress [116], the 
in vivo investigation of combined exposure using a CD-1 mice model was performed. 
his study reinforces the need to have a thorough background check on patients in terms 
ors and oncologists before 
procedures such as radiotherapy are administered. Unfortunately, the risk assessment in 
most cases formed with on that the ag  studied acts 
independently of other agents, even though interaction studies n that, at high 
exposures, the action of one agent can be influenced by simultaneous exposure to the 
other agents [147]. Previous com re studies involving radiation and other 
agents h  the measu arious end poin g lung cancer, 
mutatio
ogen peroxide (H2O2; 10 mM) according to the method described by Aebi (Aebi, 






of their previous and current drinking behaviors by doct
 is per an assumpti ent being
 have show
bined exposu
ave focused on rements of v ts, includin
ns, tumor incidence, liver carcinomas and foci, and many others, but not 
antioxidant status [148-151]. In this study, therefore, the levels of reduced glutathione, 
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which is the most important antioxidant in the living systems, having a thiol functional 
group that enables it to scavenge free radicals and maintains the redox status of the cells 
was measured. The GSSG levels were also measured, and the GSH:GSSG ratios, MDA 
levels, and antioxidant enzyme activities (CAT and GR) as a way of determining how 
combined exposure to ethanol, followed by ionizing radiation, affects the antioxidant 
status of mice were determined . Since ethanol metabolism, which takes place primarily 
in the liver is associated with most pathological conditions of the liver [152-154], all of 
the parameters mentioned were determined for the liver. Additionally, the GSH and CYS 
levels in the brains of the mice were determined, since ethanol has been documented to 
cross the blood brain barrier [155-156], and CYS levels in the kidneys.  
The GSH levels in the livers and brains of CD-1 mice were lowest in our chronic 
high-dose ethanol combined exposure group, and highest in the control. The ROS and 
free radicals produced during ethanol metabolism have been shown to cause oxidative 
stress and lipid peroxidation in the liver and brain [157-159]. Lieber reported depletion of 
hepatic GSH after chronic alcohol consumption in experimental animals and humans 
[160], and Borek reported that radiation at doses used in radiotherapy depletes tissue 
antioxidants such as alpha tocopherol, and Vitamins A, C and E [161]. An investigation 
conducted by Zentella et al. [162] concluded that ethanol intoxication decreased GSH 
levels. GSH performs many essential functions in cells, such as scavenging free radicals, 
maintaining the essential thiol status of proteins by preventing oxidation of –SH groups 
or by reducing difulfide bonds induced by oxidative stress, detoxifying electrophiles, 
modulating critical cellular processes such as DNA synthesis and immune function, and 
providing a reservoir for cysteine [163-166].  Here, chronic ethanol administration 
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induced a state of oxidative stress in the mice, lowering the levels of antioxidants and 
interfering with the normal functioning of the antioxidant enzymes.  When the mice were 
exposed to ionizing radiation, further oxidative stress resulted, since the antioxidant 
levels were already too low to cope with the increased production of ROS. Antioxidants 
and antioxidant enzymes form the defense system against oxidative damage by ROS in 
biological systems [167]. When this defense system is broken, tissue damage and 
pathological conditions result. 
 The result of this investigation showed that GSSG levels were significantly 
higher in the high-dose ethanol combined exposure group as compared to both the control 
and the single agent exposure groups. The hydrogen peroxide formed in the cells is 
reduced by GSH in the presence of glutathione peroxidase enzyme to form water, and in 
the process, GSH is oxidized to GSSG. The GSSG is then reduced back to GSH by 
glutathione reductase enzyme at the expense of NADPH. This forms a redox cycle which 
keeps the levels of GSSG low and maintains the equilibrium between oxidants and 
antioxidants in the cell [168]. When the cells experience conditions of severe oxidative 
stress because of chronic exposure to ethanol or ionizing radiation, their ability to reduce 
GSSG back to GSH can be overcome, resulting in accumulation of GSSG within the 
cytosol. The cells, therefore, have high GSSG levels and low GSH levels, resulting in a 
low GSH:GSSG ratio. The results of this investigation showed that the GSH:GSSG ratio 
was significantly lower in the combined exposure groups in comparison to the control 
and the single agent exposure groups, suggesting that the GSH-GSSG redox cycle could 
not cope with the substantial amounts of GSSG that were being formed to maintain the 
oxidant-antioxidant equilibrium of the cells. 
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 The catalase activity in the livers of the mice in this study was significantly lower 
in the combined exposure groups as compared to the control and single agent exposure 
groups. The study conducted by Escobar et al. on superoxide dismutase and catalase 
inactivation by singlet oxygen and peroxyl radicals showed that these ROS lowered the 
activity of catalase [169]. Ribiere et al. have shown that ethanol administration lowers the 
activity of the catalase enzyme [170], while Potier et al. reported a decrease in catalase 
activity in ox liver by radiation [171]. The catalase enzyme, which is most abundant in 
the liver, decomposes hydrogen peroxide to oxygen and water by a dismutation process. 
The active sites of catalase enzyme is altered by reactive oxygen species, rendering them 
unable to carry out their catalytic functions. The results showed that the increased levels 
of ROS induced by exposure to ethanol and ionizing radiation significantly decreased the 
activity of catalase in the liver. 
 Glutathione reductase activity was significantly higher in the liver of the mice in 
the combined exposure groups as compared to both the control and the single agent 
exposure groups. Studies have shown that exposure to both ethanol and ionizing radiation 
increase the activity of GR [171-173]. GR catalyzes the reduction of oxidized glutathione 
(GSSG) to reduced glutathione (GSH), maintaining adequate levels of reduced cellular 
GSH in the glutathione redox cycle. This reaction requires one mole of NADPH as a 
cofactor, which is oxidized to NADP+ for every mole of GSSG reduced, and two moles 
of GSH are produced. When the cells are experiencing oxidative stress, more GSH is 
consumed and large amounts of GSSG are produced. The activity of GR rises to cope 
with the increased amounts of GSSG being produced. The highest activity of GR 




osure groups could have been orchestrated by exposure to 
ethanol
 greater oxidative stress in the liver than single agents did and most affected the 
antioxidant status. 
The liver cysteine levels in this study were lowest in the combined exposure 
groups as compared to single agent and control groups, while the brain cysteine levels 
showed gradual decrease from the control, which had the highest level, to the high-dose 
ethanol combined exposure, which had the lowest level. CYS levels in the kidney showed 
fluctuations, without any particular pattern. Wlodek et al. have reported a decrease in the 
levels of cysteine in the livers of mice after chronic exposure to ethanol [174], and 
Dewey  et al. [175] have shown that interconversion of cysteine to cystine, which is an 
oxidation process, is induced by X-rays, and can induce alterations in cysteine levels. The 
low levels of cysteine in the livers of combined exposure groups as compared to the 
control and the single agent exp
 and ionizing radiation, both of which have been proved to induce ROS capable of 
initiating the oxidation of cysteine. Fluctuations of cysteine levels in the brains and 
kidneys could have been brought about by degradation of GSH, a process that is induced 
by ROS, and by oxidation of cysteine to cystine. 
The MDA data from this investigation showed that the high-dose ethanol 
combined exposure group had the highest levels of MDA while the control group had the 
lowest. Both ethanol and ionizing radiation have been individually shown to induce lipid 
peroxidation, which is indexed by the increased levels of MDA [176-180]. Ethanol 
metabolism is characterized by events such as acetaldehyde formation, CYP2E1-
mediated 1-hydroxyethyl radical formation, ROS production, increase in the 
NADH/NAD+ ratio, causing the reduction of ferric iron to ferrous iron, with 
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accompanying production of hydroxyl radicals. These events lead to lipid peroxidation 
and production of MDA and 4-hydroxynonenal (4-HNE). The ROS produced by ionizing 
radiatio
 for the repair of the damaged DNA 
molecu
by ionizing radiation on CD-1 mice as a model in vivo system, completing the 
n attack polyunsaturated fatty acids (PUFA) in the liver, producing MDA and 
lipid peroxides. Exposure to ethanol, followed by radiation, enhanced the generation of 
enormous amounts of ROS. These, in turn, attacked the cell membrane lipids, 
mitochondrial membrane and other cellular organelles, forming lipid aldehydes and 
peroxides. The data from the investigation supported this observation. 
The findings from this investigation showed that all of the white blood cell 
parameters were significantly lower in the high-dose ethanol combined exposure and 
XRT only groups than in all of the other groups, while the control had the highest values, 
with exception of the high-dose ethanol only group, which seemed to deviate from this 
observation. The red blood cell parameters also followed this general trend, more 
notably, the platelet and mean platelet volume values, which were lowest in the high-dose 
ethanol combined-exposure group. The destructive effects of the ROS are more 
pronounced on the DNA molecules, causing single and double strand breaks. Rapid 
proliferation of the blood cells does not allow
les, resulting in heightened apoptosis. This explains the dramatic changes in the 





This investigation has elucidated the effects of chronic ethanol exposure, followed 
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investigation on the effects of combined exposure to ethanol and ionizing radiation on 
model in vitro and in vivo systems. The in vivo results are in agreement with the in vitro 
data from all of the major parameters that were measured, confirming that there seems to 
be an interaction between ethanol and ionizing radiation in the biological systems, which 
is more significant with higher doses of radiation and ethanol. Based on these findings, it 
would appear to be good practice by doctors and oncologists to seriously consider the 






 the fact that both ethanol and ionizing radiation have individually been shown to 
induce oxidative stress in biological systems, a deliberate effort should be made to 
educate patients on the potential dangers of these agents, particularly when present in 
biological systems simultaneously. Further investigation of combined exposure that 
would involve chronic ethanol intake, tobacco smoking, and ionizing radiation in a 
clinical setup is recommended. This would model a chronic high-dose alcohol and 
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2-Mercaptoethylamine (cysteamine) is an aminothiol compound used as a drug 
for the treatment of cystinosis, an autoso al recessive lysosomal storage disorder. 
tec plex 
or labor intensive. Therefore, we have developed a new rapid, sensitive, and simple 
method for liver, and 
plasma), using N-(1-pyr ing agent and reversed-
ph n 
method (λex = 330 nm, λem = 376 nm). The mobile phase was acetonitrile and water 
(70:30) with acetic acid and o-phosphoric acid (1 ml/L). The calibration curve for 
cysteamine in serine borate buffer (SBB) w
M (r2 = 0.9993), and in plasma and liver matrix, the r2 values were 0.9968 and 0.9965, 
 The coefficients of the variation for the within-run and between-run 
recisions ranged from 0.68% to 9.90% and 0.63% to 4.17 %, respectively. The 
ercentage of relative recovery ranged from 94.1% to 98.6%.  
 








Because of cysteamine’s important role in clinical settings, its analysis by sensitive 
hniques has become pivotal. Unfortunately, the available methods are either com
 determining cysteamine in biological samples (brain, kidney, 
enyl) maleimide (NPM) as the derivatiz
ase high performance liquid chromatography (HPLC) with a fluorescence detectio










, involving incubation of 
mples in the dark, deproteinisation, coupled enzyme reactions, and pre-treatment of the 
steamine in tissues from the brain, kidney, liver, and plasma. In this 
udy, we have used N-(1-pyrenyl) maleimide (NPM), which has high affinity for free 
iols as the derivatizing agent [10]. The derivatization procedure does not require 
revious extraction and takes place at room temperature with an incubation period of 
nly 5 min. The adduct formed is stable for at least 4 weeks at 4oC and reversed-phase 
2-Mercaptoethylamine (cysteamine) is an aminothiol compound used as a drug 
for the treatment of cystinosis [1]. The deficiency of a cystine carrier in the lysosomal 
membrane leads to cystine accumulation within the lysosomes, ultimately crystallizing in 
vital organs such as the liver, kidney, spleen, intestines, and cornea [2, 3]. The kidney is 
most sensitive to cystine accumulation that causes renal tubular Fanconi syndrome to 
develop in children 6 to 12 months of age [4, 5]. Cysteamine crosses the plasma and 
lysosomal membranes and reacts with the crystallized cystine within the lysosomes to 
form cysteine and cysteine-cysteamine mixed disulfides, which leave through the lysine 
porter [6]. The thiol functional group in cysteamine makes it a potential antioxidant in 
oxidative stress conditions such as after radiotherapy.  
Because of cysteamine’s important role in clinical settings and its potential future 
applications as an antioxidant, it has become necessary to develop an analytical method 
for detecting cysteamine in biological samples. Various derivatizing reagents and 
procedures have been described in the literature for cysteamine analysis [7-9]. These 
procedures, however, are either complex or time-consuming
sa
biological samples. We have, thus, developed a method that is simple, sensitive, and 







HPLC is used for the quantitation. Various analytical methods have been cited in the 
literatu
o
ml of saline solution. The animals were then anesthetized according to the University of 
re for the determination of cysteamine in biological fluids, such as ion exchange 
column chromatography [11], high voltage electrophoresis [12], electrochemical 
detection [13, 14], and gas chromatography with flame photometric detection [15]. 
However, these methods lack sensitivity and have generally not been used with tissue 
samples to determine cysteamine. Because of this, we used reversed-phase HPLC with 
fluorescence detection since this method is very sensitive and specific for NPM-thiol 
adducts, in detecting and quantitating cysteamine in tissues of rats. 
 
EXPERIMENTAL 
Reagents and chemicals 
Acetonitrile, acetic acid, and phosphoric acid (all HPLC grade) were purchased 
from Fisher (Fair Lawn, NJ, USA). NPM and diethylenetriaminepentaacetic acid 
(DETAPAC) were obtained from Aldrich (Milwaukee, WI, USA). Cysteamine and Tris-
HCl (Trizma hydrochloride), and all the other chemicals were obtained from Sigma (St 
Louis, MO, USA).  
 
Animals 
Adult Sprague Dawley rats, weighing 250-280 g each, were obtained from 
Charles River Laboratories (Wilmington, MA, USA). The rats were housed in a 
temperature-controlled (25 C) room equipped to maintain a 12 h light-dark cycle. 
Standard rat chow (Purina rat chow) and water were given ad libitum. After over-night 
fasting, cysteamine was administered intraperitoneally at 300 mg/kg of body weight in 1 
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Missouri Animal Care Regulations. Blood samples were collected after 30 min via 
intracardiac puncture into the sterile polystyrene tubes containing heparin as an 
anticoagulant. The animals were then sacrificed and liver, kidney, and brain samples 
were obtained and kept on ice for immediate derivatization and analysis. The remaining 
tissue samples were kept at -70oC for later analysis. The blood was centrifuged for 5 min 
at 1000 x g to obtain plasma, which was immediately derivatized with NPM. 
 
Preparation of solutions for calibration 
Stock solutions of cysteamine were prepared by dissolving 1.2 mg of cysteamine 
orate buffer (SBB) to make a 1 mM solution of cysteamine, which 
BB to obtain 100 µM and 10 µM stock solutions. The stock 
solution
lenetriaminepentaacetic aced (DETAPAC) in 1 L of HPLC grade 
water (pH = 7.0). NPM (1 mM) solution was prepared by dissolving 0.003 g of NPM in 
cetonitrile. Antioxidant buffer was prepared by dissolving 1.2 g disodium 
phosph
in 10 mL of serine b
was further diluted with S
s were used to prepare standards for the calibration curve. Appropriate volumes 
of cysteamine stock solutions were added to plasma and tissue samples in order to obtain 
final concentrations of 50, 100, 200, 400, 600, 800, 1000, and 1200 nM for the calibration 
standard. SBB was prepared by adding 15.74 g Tris-HCl, 0.618 g borate, 0.525 g serine, 
and 0.393 g diethy
10 mL a
ate, 0.32 g sodiumdihydrogen phosphate, 100 µL butylated hydroxytoluene (BHT) 
solution (0.1102 g BHT in 1 mL 100 % ethanol), 0.841 g aminotriazole, 0.039 g 






The HPLC system (Thermo Electron Corporation) consisted of a Finnigan ™ 
Spectra SYSTEM SCM1000 Vacuum Membrane Degasser, Finnigan ™ Spectra 
SYSTEM P2000 Gradient Pump, Finnigan ™ Spectra SYSTEM AS3000 Autosampler, 
and Finnigan ™ Spectra SYSTEM FL3000 Fluorescence Detector (λex = 330 nm and 
λem = 376 nm). The HPLC column was a Reliasil ODS-1 C18 column (5 µm silica 
packing material) with 250 x 4.6 mm (Column Engineering, Ontario, CA, USA). The 
% HPLC water and was adjusted to a pH of 
about 2
ere prepared by taking 
appropriate volumes of stock solutions to obtain concentrations of 0, 50, 100, 200, 400, 
600, 800, 1000, and 1200 nM in the tissue matrix. The resulting mixtures were 
derivatized with 750 μL of 1.0 mM NPM solution in acetonitrile and left to stand for 5 
mobile phase was 70% acetonitrile and 30
 through the addition of 1 mL of both acetic acid and o-phosphoric acid. The 
NPM derivatives were eluted from the column isocratically at a flow rate of 1 mL/min. 
The chromatographic column temperature was ambient. There were very minor 
fluctuations of retention times which could be neglected. 
 
Assay procedures 
Derivatization of cysteamine 
The tissue samples from the livers, kidneys, and brains of adult Sprague Dawley 
rats were homogenized (0.15 g/ml) in antioxidant buffer (prepared as described above 
under solution preparation) to avoid oxidation. The plasma samples were diluted (1/5) 
before derivatization. 10 μL of tissue homogenates or diluted plasma samples were mixed 
with 240 μL of SBB and then derivatized at room temperature with 750 μL of NPM to 
form fluorescent derivatives. Standard solutions of cysteamine w
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min at room temperature. At the end of the reaction time, 10 µL of 2 N HCl solution were 
added 
L of the diluted dye were added 
 50 µL of the homogenized sample. The mixture was incubated at room temperature for 
sorbance was measured at 595 nm by a spectrophotometer. The 
sent in the homogenized samples were obtained by 
compar
to stop the reaction and stabilize the adducts. The final pH of the solution was 
maintained at about 2 which is ideal for the stability of the NPM-cysteamine adducts. The 
derivatized samples were filtered through a 0.45 µm acrodisc filter, and then injected into 
the column in a reversed-phase HPLC system.  
 
Protein assay 
The protein contents of different tissue samples were determined by using the 
Bradford  method [16] in order to compare the concentration levels of CSH obtained 
from the tissue samples. The homogenized samples were diluted to appropriate 
concentrations prior to determination of protein levels. Concentrated coomasie blue (Bio-
Rad) was diluted 1:5(v/v) with distilled water; then 2.5 m
to
5 min, then the ab
concentrations of protein pre
ing the absorbance values of the samples against the standard curve. The standard 




The calibration curves of CSH were plotted by using integrated peak areas as the 
y-axis vs. standard CSH concentrations (0, 50, 100, 200, 400, 600, 800, 1000, and 1200 
nM) as the x-axis. Linearity for the standards (without the tissue matrix) was obtained 
 
 103
over a full range of 0-1200 nM with the calibration curve: y = 876.35x -5224.7 and a 
correlation coefficient: r2 = 0.9993. Linearity for standards (with the tissue matrix) was 
also obtained over a full range of 0-1200 nM, with the calibration curves in the plasma 
and liver tissue matrix: y = 890.33x – 12871 and y = 856.62x – 14886 respectively. The 
correlation coefficients were r2 = 0.9968 in the plasma matrix and r2 = 0.9965 in the liver 
tissue m trix. 
Accura
he matrix. 
etween-run precision was determined by derivatizing six replicates of CSH-spiked 
ples, at concentrations ranging from 50-1000 nM in three 




cy, precision, and recovery 
Six replicates of plasma and tissue samples were prepared, spiked with 50 nM, 
100 nM, 600 nM, and 1000 nM of CSH, and then analyzed in order to determine 
accuracy. The concentration points (50, 100, 600, and 1000 nM) were used as the true 
values in the calculation of the deviations between the true values and the measured 
values. The calculated deviations were then expressed as percentage to yield a relative 
deviation (RD), which was used as a measure of accuracy. Within-run precision was 
determined by analyzing six replicates of CSH-spiked control plasma and tissue samples, 
at concentrations ranging from 50-1000 nM in one analytical run, and comparing the 
CSH concentrations calculated from the peak areas of the six replicates in t
B
control plasma and tissue sam
different analytical ru
f the six replicates in each matrix. The coefficients of variation were calculated in 
each matrix and used as a measure of precision. Relative recovery was determined by 
spiking the brain, kidney, liver, and plasma samples with 50 nM, 100 nM, 600 nM, and 
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1000 nM CSH in three replicates. The recoveries were calculated by comparing the 
analytical results for the spiked samples with the unspiked pure standards at the four 
mentioned concentrations that represented 100 % recovery. The coefficients of variation 
(CV) for between-run and within-run precision, accuracy, and relative recovery of the 
samples spiked with CSH (50, 100, 600, 1000 nM) in the tissue matrix and standards are 
reported in Table 1. The coefficients of variation for within-run precision and between-
n precision ranged from 0.68% to 9.90% and 0.63% to 4.17 %, respectively. The 
 obtained at 50 nM. The percentages of relative 
recover
ru
within-run precision of 9.90% was
y ranged from 94.1% to 98.6%.  
 
Sensitivity and stability 
The lower limit of quantitation (LLOQ) was the concentration of CSH when its 
peak area was  10 times that of the peak area of the blank (signal-to-noise = 10). The 
LLOQ of CSH was 50 nM (0.05 nmol/ml), and the detection limit was 10 nM (0.01 
nmol/ml) (signal-to-noise = 3) with 5 µL injected sample volume. The autosampler 
stability was measured by determining the six replicates of derivatized CSH spiked 
plasma and tissue samples at three concentrations (100, 600, and 1000 nM). These were 
kept in HPLC autosampler vials and stored at room temperature following 0, 6, 12, 24, 
and 48 h of sample derivatization, or stored at 4oC for 1, 3, 7, and 14 days after sample 
derivatization. The relative standard deviation was found to be less than 8 % when the 
derivatized samples were stored at room temperature, and less than 15 % for samples 




Investigating interference from other thiols 
A standard mixture of 600 nM of cysteamine (CSH), N-acetyl-L-cysteine (NAC), 
glutathione (GSH), cysteine (CYS), and homocysteine (HCYS), in a plasma matrix was 
derivatized with NPM and analyzed by reversed-phase HPLC, as shown in the 
chromatogram in Figure 2. All of the biological thiols mentioned above elute before CSH 
and do not interfere with its detection. 
 
RESULTS 
In this investigation, CSH was derivatized with NPM and analyzed using the 
reversed-phase HPLC with fluorescence detection method in isocratic mode. The tissue 
er) from treated adult Sprague Dawley rats were homogenized, 
derivat
togram. Figure 4 (b) shows the chromatogram of the liver sample obtained 
from a rat that was administered 300 mg/kg body weight of CSH and sacrificed 30 min 
samples (brain, kidney, liv
ized with NPM, and analyzed. The plasmas were also analyzed. Tissues of control 
animals were spiked with varying concentrations of CSH and analyzed. Figure 1 shows 
the derivatization reaction in which the thiols reacted with NPM to form fluorescent 
adducts. Figure 2 shows the chromatogram of derivatized standard mixed thiols (600 
nM): NAC, GSH, CYS, HCYS, and CSH in a plasma matrix. The biological thiols (CYS, 
GSH, NAC, and HCYS) do not interfere with the detection of CSH since their peaks 
come out before the CSH peak. Figure 3 is the chromatogram of a kidney sample 
obtained from an animal administered 300 mg/kg body weight of CSH and sacrificed 30 
min later. Figure 4 (a) shows the chromatogram of the control liver sample from a 




later. The CSH peak was observed at 17 min. The concentrations of CSH obtained in the 
plasma
water adduct, which results from the reaction of 
xcess NPM with water. 
DISCU
 and tissues are reported in Table 2. The levels of other important biological thiols 
(such as GSH and CYS) in the tissue samples and plasma were calculated using the thiol 
concentrations (nM) of homogenized tissue solutions, divided by the protein content in 
the tissue and expressed as nmol/mg protein. This data is reported in Table 2. The 




In spite of the attempts that have been made to analyze cysteamine in biological 
samples, to the best of our knowledge, no detailed study has been reported in the recent 
past on determination of cysteamine in biological samples. Ricci et al. (1983) published 
an analytical method for determining cysteamine in biological samples but the 
derivatization procedure used is complex, involving coupled enzyme reactions along with 
detailed pre-treatment of the samples. Furthermore, no clear detection method has been 
shown. Stachowicz et al. (1998) have reported determination of cysteamine in human 
serum.  However, their work did not include the determination of cysteamine in other 
tissue samples such as the brain, kidney, and liver. Moreover, the derivatizing agent they 
used was mono bromobimane (mBBr) as a fluorescent probe, which can measure many 
biologically important thiols since it is both specific and sensitive to thiols. However, the 
sample preparation and derivatization are complex and time consuming, and involve the 
incubation of samples in the dark. In our study, we used N-(1-pyrenyl) maleimide (NPM) 
as the derivatizing agent [17]. NPM is very specific for thiols. The derivatization 
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procedure using NPM is very simple (not requiring any special conditions), and the 
reactions take place at room temperature under ordinary laboratory conditions. NPM has 
the added advantage of increased sensitivity and rapid analysis, compared to the mBBr 
method. Although NPM has hydrolysis peaks, these come up well before the cysteamine 
peak; no interference has been observed.  
The methods of detection reported in the literature, such as high performance 
liquid chromatography with ultraviolet detection [18], ion exchange column 
hromatography, and capillary electrophoresis [19, 20, 21], are well documented as 




cence detection for determining cysteamine in biological samples. This is a very 
sensitive method with high reproducibility and precision. The LLOQ of CSH in 
biological samples by our method was 0.05 nmol/ml, and the detection limit was 0.01 
nmol/ml (signal-to-noise = 3), which is better than the LLOQ of 0.1 nmol/ml of plasma 
reported by Kusmierek et al. using HPLC with ultraviolet detection after precolumn 
derivatization, and the LOD of 0.061 µmol/L reported by Lochman et al using high-
throughput capillary electrophoretic method for determination of total aminothiols in 
plasma and urine [18, 9]. A plasma cysteamine concentration of 5µM in humans 8 hours 
after an oral dose of 1200 mg is reported by Stachowicz et al [8]. It is important to note 
that cysteamine easily undergoes oxidation at room temperature to form mixed disulfides, 
therefore, cysteamine should be dissolved in serine borate buffer, in which it remains 
stable for 7 days at 4oC. In this study, we have demonstrated that HPLC with 
fluorescence detection, using NPM as the derivatizing agent, is a very suitable method for 
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analyzing and detecting cysteamine in biological samples. The method is rapid, simple, 
and sensitive, and could be used in health institutions for pharmacokinetic studies. 
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igure 2. Chromatogram of derivatized standard mixed thiols (600 nM): NAC, GSH, 
YS, HCYS, and CSH in a plasma matrix. Separation conditions: an ODS-1 C18 Column 
 µm packing material) with 250 x 4.6 mm (i.d) was used for the separation. The NPM 
erivatives were measured by a fluorescence detector (λex = 330 nm and λem = 376 nm). 
low rate was 1ml/min. The mobile phase was 70% acetonitrile and 30% HPLC water 
nd was adjusted to a pH of about 2 through the addition of 1 mL of both acetic acid and 




















































Figure 3. Chromatogram of a kidney sample obtained from an animal sacrificed 30 min 
after the administration of 300 mg/kg body weight of CSH. The concentrations of GSH, 
CYS, and CSH were 3.3 ± 1.2, 34.5 ± 6.3, and 24.5 ± 1.2 nmol/mg protein respectively.  








































































igure 4. (a) Chromatogram of a control liver sample obtained from an animal 
dministered phosphate buffered saline solution only. (b) Chromatogram of a liver 
ample obtained from an animal sacrificed 30 min after the administration of 300 mg/kg 












Table 1. Between-run and within-run precisions, accuracy, and relative recovery of 
replicate samples spiked with CSH (50, 100, 600, and 1000 nM) in plasma and tissue 
sample matrices, and standards. 
 

















































(Percentage relative recovery is reported as the average relative recovery ± 























Plasma  units w µM, u r tissu les are in nmol/mg protein. The 




Samples (n=3)  CSH GSH CYS 
C 13.6 ontrol ND ± 1.1 1.6 ± 0.3 
Brain 
CSH-treated .8 ± 1.7 15.8 ± 1.9 ± 0.5 
C ND 2.1 ±
Kidney 
CSH-treated 24.5 ± 1.2 3.3 ± 1.2 34.5 ± 6.3 
Co ND 19.2 ± 3.4 ± 0.2 
CSH-treated  ± 1.6 21.3 
Control ND 6.2 ± 1.1 15.6 ± 1.8 
CSH-treated 7.3 ± 1.4 
21   2.4 
 0.5 ontrol 28.2 ± 3.1 
ntrol  3.7 
± 4.2 
Liver 
9.5  2.7± 0.4 
Plasma 
22.4 ± 2.8  18.4 ± 2.9 
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